-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 JJGgb4qvdpCD9QAjYwsq9ontaMQ/iSTb+lo86Z3c97jU8ZNvG3kkLPL2x/Ir7fWV
 reWpY4Zvc4jO7r5UtBDUtA==

<SEC-DOCUMENT>0000950123-09-047959.txt : 20091002
<SEC-HEADER>0000950123-09-047959.hdr.sgml : 20091002
<ACCEPTANCE-DATETIME>20091002153751
ACCESSION NUMBER:		0000950123-09-047959
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20091002
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20091002
DATE AS OF CHANGE:		20091002

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MOOG INC
		CENTRAL INDEX KEY:			0000067887
		STANDARD INDUSTRIAL CLASSIFICATION:	MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT [3590]
		IRS NUMBER:				160757636
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05129
		FILM NUMBER:		091102228

	BUSINESS ADDRESS:	
		STREET 1:		PLANT 24
		CITY:			EAST AURORA
		STATE:			NY
		ZIP:			14052-0018
		BUSINESS PHONE:		7166522000

	MAIL ADDRESS:	
		STREET 1:		PLANT 24
		CITY:			EAST AURORA
		STATE:			NY
		ZIP:			14052
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>l37710e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>






<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, DC 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Date of Report (Date of earliest event reported): October&nbsp;2, 2009</B></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>MOOG INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>New York</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>1-5129</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>16-0757636</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or Other Jurisdiction <BR>
of Incorporation)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Commission<BR>
File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(I.R.S. Employer<BR>
Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>East Aurora, New York</B><BR>
(Address of principal executive offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>14052-0018</B><BR>
(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Registrant&#146;s Telephone Number, Including Area Code: <B>(716)&nbsp;652-2000</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>N/A</B><BR>
(Former name or former address, if changed since last report)</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)<BR>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
</DIV>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD></TD><TD colspan="8"><A HREF="#000">Item&nbsp;8.01 Other Events.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#001">Item&nbsp;9.01 Financial Statements and Exhibits.</A></TD></TR>
<TR><TD colspan="9"><A HREF="#002">SIGNATURE</A></TD></TR>
<TR><TD colspan="9"><A HREF="#003"><U>EXHIBIT INDEX</U></A></TD></TR>
<TR><TD colspan="9"><A HREF="l37710exv1w1.htm">EX-1.1</A></TD></TR>
<TR><TD colspan="9"><A HREF="l37710exv5w1.htm">EX-5.1</A></TD></TR>
<TR><TD colspan="9"><A HREF="l37710exv99w1.htm">EX-99.1</A></TD></TR>
<TR><TD colspan="9"><A HREF="l37710exv99w2.htm">EX-99.2</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>




<!-- link2 "Item&nbsp;8.01 Other Events." -->
<DIV align="left"><A NAME="000"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;8.01 Other Events.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On September&nbsp;30, 2009 and October&nbsp;2, 2009, Moog Inc. (the &#147;Company&#148;) issued press releases
announcing the pricing and closing, respectively, of the public offering and sale of 2,675,000
shares of Class&nbsp;A common stock, which includes 175,000 shares sold pursuant to the underwriters&#146;
over-allotment option, at a price of $29.50 per share. The information contained in those press
releases, which are filed as exhibits 99.1 and 99.2 to this Current Report on Form 8-K, are
incorporated herein by reference.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company is updating its previous financial projections for net earnings and diluted earnings
per share for fiscal year 2010. The updated projections reflect the closing of the public offering
and sale of common stock described herein to repay a portion of the outstanding indebtedness under
the revolving bank credit facility that was borrowed to pay for the acquisition of the flight
control actuation business of GE Aviation Systems. Giving effect to the final pricing of the
offering and the exercise in part of the underwriters&#146; over-allotment option granted in the
offering, net earnings and diluted earnings per share for fiscal year 2010 are now forecasted to be
$103&nbsp;million and $2.25, respectively. Given the uncertainty in the global economy, these forecasted
amounts are centered within a range of plus or minus $.10 per share.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Cautionary Statement</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Information included herein or incorporated by reference that does not consist of historical facts,
including statements accompanied by or containing words such as &#147;may,&#148; &#147;will,&#148; &#147;should,&#148;
&#147;believes,&#148; &#147;expects,&#148; &#147;expected,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;projects,&#148; &#147;approximate,&#148; &#147;estimates,&#148;
&#147;predicts,&#148; &#147;potential,&#148; &#147;outlook,&#148; &#147;forecast,&#148; &#147;anticipates,&#148; &#147;presume&#148; and &#147;assume,&#148; are
forward-looking statements. Such forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995. These statements are not
guarantees of future performance and are subject to several factors, risks and uncertainties, the
impact or occurrence of which could cause actual results to differ materially from the expected
results described in the forward-looking statements. These important factors, risks and
uncertainties include (i)&nbsp;fluctuations in general business cycles for commercial aircraft, military
aircraft, space and defense products, industrial capital goods and medical devices, (ii)&nbsp;our
dependence on government contracts that may not be fully funded or may be terminated, (iii)&nbsp;our
dependence on certain major customers, such as The Boeing Company and Lockheed Martin, for a
significant percentage of our sales, (iv)&nbsp;the possibility that the demand for our products may be
reduced if we are unable to adapt to technological change, (v)&nbsp;intense competition which may
require us to lower prices or offer more favorable terms of sale, (vi)&nbsp;our significant
indebtedness, which could limit our operational and financial flexibility, (vii)&nbsp;the possibility
that new product and research and development efforts may not be successful which could reduce our
sales and profits, (viii)&nbsp;increased cash funding requirements for pension plans, which could occur
in future years based on assumptions used for our defined benefit pension plans, including returns
on plan assets and discount rates, (ix)&nbsp;a write-off of all or part of our goodwill or intangible
assets, which could adversely affect our operating results and net worth and cause us to violate
covenants in our bank agreements, (x)&nbsp;the potential for substantial fines and penalties or
suspension or debarment from future contracts in the event we do not comply with regulations
relating to defense industry contracting, (xi)&nbsp;the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">potential for cost overruns on development jobs and fixed price contracts and the risk that actual
results may differ from estimates used in contract accounting, (xii)&nbsp;the possibility that our
subcontractors may fail to perform their contractual obligations, which may adversely affect our
contract performance and our ability to obtain future business, (xiii)&nbsp;our ability to successfully
identify and consummate acquisitions, and integrate the acquired businesses and the risks
associated with acquisitions, including the risks that the acquired businesses do not perform in
accordance with our expectations, and that we assume unknown liabilities in connection with the
acquired businesses for which we are not indemnified (all of which risks are presented by our
recently announced acquisition of the flight control actuation business from GE Aviation Systems),
(xiv)&nbsp;our dependence on our management team and key personnel, (xv)&nbsp;the possibility of a
catastrophic loss of one or more of our manufacturing facilities, (xvi)&nbsp;the possibility that future
terror attacks, war or other civil disturbances could negatively impact our business, (xvii)&nbsp;that
our operations in foreign countries could expose us to political risks and adverse changes in
local, legal, tax and regulatory schemes, (xviii)&nbsp;the possibility that government regulation could
limit our ability to sell our products outside the United States, (xix)&nbsp;product quality or patient
safety issues with respect to our medical devices business that could lead to product recalls,
withdrawal from certain markets, delays in the introduction of new products, sanctions, litigation,
declining sales or actions of regulatory bodies and government authorities, (xx)&nbsp;the impact of
product liability claims related to our products used in applications where failure can result in
significant property damage, injury or death and in damage to our reputation, (xxi)&nbsp;the possibility
that litigation may result unfavorably to us, (xxii)&nbsp;our ability to adequately enforce our
intellectual property rights and the possibility that third parties will assert intellectual
property rights that prevent or restrict our ability to manufacture, sell, distribute or use our
products or technology, (xxiii)&nbsp;foreign currency fluctuations in those countries in which we do
business and other risks associated with international operations, (xxiv)&nbsp;the cost of compliance
with environmental laws, (xxv)&nbsp;the risk of losses resulting from maintaining significant amounts of
cash and cash equivalents at financial institutions that are in excess of amounts insured by
governments, (xxvi)&nbsp;the inability to modify, to refinance or to utilize amounts available to us
under our credit facilities given uncertainties in the credit markets, (xxvii)&nbsp;our ability to meet
our credit facilities&#146; restrictive covenants, breach of which could result in a default under our
credit agreements and (xxviii)&nbsp;the risk that our credit rating is lowered or that other action is
taken by credit rating agencies, or other third parties, that negatively impacts our credit rating
or creditworthiness, (xxix)&nbsp;our customer&#146;s inability to pay us due to adverse economic conditions
or their inability to access available credit. The factors identified above are not exhaustive. New
factors, risks and uncertainties may emerge from time to time that may affect the forward-looking
statements made herein. Given these factors, risks and uncertainties, investors should not place
undue reliance on forward-looking statements as predictive of future results. We disclaim any
obligation to update the forward-looking statements made in this release.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link2 "Item&nbsp;9.01 Financial Statements and Exhibits." -->
<DIV align="left"><A NAME="001"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9.01 Financial Statements and Exhibits.</B>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Exhibits.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">1.1</TD>
    <TD width="3%">&nbsp;</TD>
    <TD>Underwriting Agreement, dated September&nbsp;29, 2009
between Moog Inc. and Cowen and Company, LLC</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">5.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Opinion of Hodgson Russ LLP</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">23.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Consent of Hodgson Russ LLP (included in Exhibit&nbsp;5.1)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">99.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Press release dated September&nbsp;30, 2009</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">99.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Press release dated October&nbsp;2, 2009</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>
<!-- link1 "SIGNATURE" -->
<DIV align="left"><A NAME="002"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>MOOG INC.</B><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">Dated:  October 2, 2009&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Jennifer Walter
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Jennifer Walter&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Controller&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>
<!-- link1 "<U>EXHIBIT INDEX</U>" -->
<DIV align="left"><A NAME="003"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>EXHIBIT INDEX</B></U>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Exhibit</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Description</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">1.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Underwriting Agreement, dated September&nbsp;29, 2009
between Moog Inc. and Cowen and Company, LLC</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Hodgson Russ LLP</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Hodgson Russ LLP (included in Exhibit&nbsp;5.1)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press release dated September&nbsp;30, 2009</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press release dated October&nbsp;2, 2009</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>l37710exv1w1.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv1w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>EXHIBIT 1.1</B>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 6pt"><U><B>EXECUTION COPY</B></U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>MOOG INC.</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Class&nbsp;A Common Stock</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><U><B>UNDERWRITING AGREEMENT</B></U>

</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt">September&nbsp;29, 2009
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Cowen and Company, LLC<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As Representative of the Several Underwriters<BR>
c/o Cowen and Company, LLC<BR>
1221 Avenue of the Americas<BR>
New York, New York 10020

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Dear Sirs:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>1. </I><FONT style="font-variant: SMALL-CAPS"><I>Introductory</I></FONT>. Moog Inc., a New York corporation (the &#147;Company&#148;), proposes to sell,
pursuant to the terms of this Agreement, to the several underwriters named in <U>Schedule&nbsp;A</U>
hereto (the &#147;Underwriters,&#148; or, each, an &#147;Underwriter&#148;), an aggregate of 2,500,000 shares of Class
A Common Stock, $1.00 par value (the &#147;Class&nbsp;A Common Stock&#148;), of the Company. The aggregate of
2,500,000 shares of Class&nbsp;A Common Stock so proposed to be sold is hereinafter referred to as the
&#147;Firm Stock&#148;. The Company also proposes to sell to the Underwriters, upon the terms and conditions
set forth in Section&nbsp;3 hereof, up to an additional 375,000 shares of Class&nbsp;A Common Stock (the
&#147;Optional Stock&#148;). The Firm Stock and the Optional Stock are hereinafter collectively referred to
as the &#147;Stock&#148;. The Class&nbsp;A Common Stock and the Class&nbsp;B Common Stock, $1.00 par value, of the
Company are hereinafter collectively referred to as the &#147;Common Stock&#148;. Cowen and Company, LLC
(&#147;Cowen&#148;) is acting as representative of the several Underwriters and in such capacity are
hereinafter referred to as the &#147;Representative&#148;.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>2. </I><FONT style="font-variant: SMALL-CAPS"><I>Representations and Warranties of the Company</I></FONT>. The Company represents and warrants to the
several Underwriters as of the date hereof and as of each Closing Date, and agrees with the several
Underwriters that:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company meets the requirements for use of Form S-3 under the Securities Act
of 1933, as amended (the &#147;Securities Act&#148;) and the rules and regulations of the
Commission (the &#147;Rules and Regulations&#148;). An &#147;automatic shelf registration statement&#148;
as defined in Rule&nbsp;405 under the Securities Act on Form S-3 (File No.&nbsp;162178) in
respect of the Stock has been filed with the Securities and Exchange Commission (the
&#147;Commission&#148;) not earlier than three (3)&nbsp;years prior to the date hereof. Such
registration statement, and any post-effective amendments thereto, are effective; and
no stop order suspending the effectiveness of such registration
statement or any part thereof has been issued and no proceeding for that purpose has
been initiated or threatened by the Commission, and no notice of objection of the
Commission to the use of such registration statement or any post-effective </TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #textcolor#; background: #bgcolor#">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>amendment
thereto pursuant to Rule&nbsp;401(g)(2) of the Rules and Regulations has been received by
the Company (the base prospectus filed as part of such registration statement, in
the form in which it has most recently been filed with the Commission on or prior to
the date of this Agreement, is hereinafter called the &#147;Base Prospectus&#148; and any
preliminary prospectus (including any preliminary prospectus supplement), if any,
relating to the Stock filed with the Commission pursuant to Rule 424(b) of the Rules
and Regulations is hereinafter called a &#147;Preliminary Prospectus&#148;). The automatic
shelf registration statement, including all exhibits thereto and including any
documents incorporated by reference and any prospectus supplement relating to the
Stock that is filed with the Commission and deemed by virtue of Rule&nbsp;430B of the
Rules and Regulations to be part of such registration statement, are hereinafter
collectively called the &#147;Registration Statement.&#148; The form of the final prospectus
relating to the Stock filed with the Commission pursuant to Rule 424(b) of the Rules
and Regulations in accordance with Section 4(a) hereof, is hereinafter called the
&#147;Prospectus&#148;. Any reference herein to the Base Prospectus, the Pricing Prospectus
(as defined below), any Preliminary Prospectus or the Prospectus shall be deemed to
refer to and include the documents incorporated by reference therein pursuant to
Item&nbsp;12 of Form S-3 under the Securities Act, as of the date of the respective
prospectus; any reference to any amendment or supplement to the Base Prospectus, any
Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any
post-effective amendment to the Registration Statement, any prospectus supplement
relating to the Stock filed with the Commission pursuant to Rule 424(b) of the Rules
and Regulations and any documents filed under the Securities Exchange Act of 1934,
as amended (the &#147;Exchange Act&#148;), and incorporated by reference therein, in each case
after the date of the Base Prospectus, such Preliminary Prospectus or the
Prospectus, as the case may be; any reference to any amendment to the Registration
Statement shall be deemed to refer to and include any annual report of the Company
filed pursuant to Section 13(a) or 15(d) of the Exchange Act after the effective
date of the Registration Statement that is incorporated by reference into the
Registration Statement.</TD>
</TR>
<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR>
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>As of the Applicable Time (as defined below) and as of the Closing Date or the
Option Closing Date, as the case may be, neither (i)&nbsp;the General Use Free Writing
Prospectus(es) (as defined below) issued at or prior to the Applicable Time and the
Pricing Prospectus (as defined below) and the information included on <U>Schedule
D</U> hereto, all considered together (collectively, the &#147;General Disclosure Package&#148;),
nor (ii)&nbsp;any individual Limited Use Free Writing Prospectus (as defined below), when
considered together with the General Disclosure Package, included or will include any
untrue statement of a material fact or omitted or will omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. As used in this paragraph (b)&nbsp;and
elsewhere in this Agreement:</TD>
</TR>

</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Applicable Time&#148; means 5:30 P.M., New York time, on September&nbsp;29, 2009 or such
other time as agreed to by the Company and the Representative.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Pricing Prospectus&#148; means the Preliminary Prospectus relating to the Stock
that is included in the Registration Statement immediately prior to the Applicable
Time including any document incorporated by reference therein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Issuer Free Writing Prospectus&#148; means any &#147;issuer free writing prospectus,&#148; as
defined in Rule&nbsp;433 of the Rules and Regulations relating to the Stock in the form
filed or required to be filed with the Commission or, if not required to be filed,
in the form retained in the Company&#146;s records pursuant to Rule 433(g) of the Rules
and Regulations.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;General Use Free Writing Prospectus&#148; means any Issuer Free Writing Prospectus
that is identified on <U>Schedule&nbsp;B</U> to this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;Limited Use Free Writing Prospectus&#148; means any Issuer Free Writing Prospectus
that is not a General Use Free Writing Prospectus.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>No order preventing or suspending the use of any Preliminary Prospectus, any
Issuer Free Writing Prospectus or the Prospectus relating to the proposed offering of
the Stock has been issued by the Commission, and no proceeding for that purpose or
pursuant to Section&nbsp;8A of the Securities Act has been instituted or threatened by the
Commission, and each Preliminary Prospectus, at the time of filing thereof, conformed
in all material respects to the requirements of the Securities Act and the rules and
regulations of the Commission thereunder and did not contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances under which
they were made, not misleading; <I>provided</I>, <I>however</I>, that the Company makes no
representations or warranties as to information contained in or omitted from any
Preliminary Prospectus, in reliance upon, and in conformity with, written information
furnished to the Company through the Representative by or on behalf of any Underwriter
specifically for inclusion therein, which information the parties hereto agree is
limited to the Underwriters&#146; Information (as defined in Section&nbsp;17).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>At the respective times the Registration Statement and any amendments thereto
became or become effective, at the date of this Agreement and at each Closing Date,
each Registration Statement and any amendments thereto conformed and will conform in
all material respects to the requirements of the Securities Act and the Rules and
Regulations and did not and will not contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein or necessary to make the
statements therein not misleading; and the Pricing Prospectus and the Prospectus and
any amendments or supplements to the Prospectus, at the time the Prospectus or any
amendment or supplement thereto was issued and at each Closing Date, conformed and will
conform in all material respects to the requirements of the Securities Act and the
Rules and Regulations
and did not and will not contain an untrue statement of a material fact or omit to
state a material fact necessary in order to make the statements therein, in light of
the circumstances under which they were made, not misleading; <I>provided</I>, </TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #textcolor#; background: #bgcolor#">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>however</I>,
that the foregoing representations and warranties in this paragraph (d)&nbsp;shall not
apply to information contained in or omitted from the Registration Statement or the
Prospectus, or any amendment or supplement thereto, in reliance upon, and in
conformity with, written information furnished to the Company through the
Representative by or on behalf of any Underwriter specifically for inclusion
therein, which information the parties hereto agree is limited to the Underwriter
Information (as defined in Section&nbsp;17). The Pricing Prospectus and the Prospectus
contains all required information under the Securities Act with respect to the Stock
and the distribution of the Stock. The statistical and market related data included
in the Registration Statement, the Pricing Prospectus, the General Disclosure
Package and the Prospectus are based on or derived from sources that the Company
believes to be reliable and accurate, and such data agree with the sources from
which they are derived. The documents incorporated by reference in the Prospectus,
when they were filed with the Commission conformed in all material respects to the
requirements of the Securities Act or the Exchange Act, as applicable, and the rules
and regulations of the Commission thereunder and none of such documents contained
any untrue statement of a material fact or omitted to state any material fact
required to be stated therein or necessary to make the statements therein not
misleading; and any further documents so filed and incorporated by reference in the
Prospectus, when such documents are filed with Commission will conform in all
material respects to the requirements of the Securities Act or the Exchange Act, as
applicable, and the rules and regulations of the Commission thereunder and will not
contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein not
misleading.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(e)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Each Issuer Free Writing Prospectus, as of its issue date and at all subsequent
times through the completion of the public offer and sale of the Stock or until any
earlier date that the Company notified or notifies the Representative as described in
Section&nbsp;4(e), did not, does not and will not include any information that conflicted,
conflicts or will conflict with the information contained in the Registration
Statement, the Pricing Prospectus or the Prospectus, including any document
incorporated by reference therein and any prospectus supplement deemed to be a part
thereof that has not been superseded or modified, or included or would include an
untrue statement of a material fact or omitted or would omit to state a material fact
required to be stated therein or necessary in order to make the statements therein, in
the light of the circumstances prevailing at the subsequent time, not misleading.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(f)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company has not, directly or indirectly, distributed and will not
distribute any offering material in connection with the offering and sale of the Stock
other than the Prospectus and other materials, if any, permitted under the Securities
Act and consistent with Section 4(b) below. The Company will file with the
Commission all Issuer Free Writing Prospectuses in the time and manner required
under Rules&nbsp;163(b)(2) and 433(d) under the Securities Act.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(g)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>(A)&nbsp;At the time of the filing of the Registration Statement and at the time the
Company or any person acting on its behalf (within the meaning, for this clause only,
of Rule 163(c) under the Securities Act) made any offer relating to the Stock in
reliance on the exemption of Rule&nbsp;163 under the Securities Act, the Company was a
&#147;well-known seasoned issuer&#148; as defined in Section&nbsp;405 under the Securities Act; and
(B) (i)&nbsp;at the earliest time after the filing of the Registration Statement that the
Company or another offering participant made a <I>bona fide </I>offer (within the meaning of
Rule&nbsp;164(h)(2) of the Securities Act) and (ii)&nbsp;as of the date hereof (with such date
being used as the determination date for purposes of this clause (B)(ii)), the Company
was not and is not an &#147;ineligible issuer&#148; as defined in Rule&nbsp;405 under the Securities
Act (without taking into account any determination by the Commission pursuant to Rule
405 that it is not necessary that the Company be considered an &#147;ineligible issuer,&#148;
including, without limitation, for purposes of Rules&nbsp;164 and 433 under the Securities
Act) with respect to the offering of the Stock as contemplated by the Registration
Statement.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(h)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company and each of its subsidiaries (as defined in Section&nbsp;15) have been
duly organized and are validly existing as corporations in good standing under the laws
of their respective jurisdictions of organization and are each duly qualified to do
business and are in good standing as foreign corporations or other legal entities in
each jurisdiction in which their respective ownership or lease of property or the
conduct of their respective businesses requires such qualification, and have all power
and authority necessary to own or hold their respective properties and to conduct the
businesses in which they are engaged, except where the failure to so qualify or have
such power or authority (i)&nbsp;would not have, singularly or in the aggregate, a material
adverse effect on the condition (financial or otherwise), results of operations,
assets, business or prospects of the Company and its subsidiaries taken as a whole or
(ii)&nbsp;impair in any material respect the ability of the Company to perform its
obligations under this Agreement or to consummate any transactions contemplated by the
Agreement, the Pricing Prospectus, the General Disclosure Package or the Prospectus
(any such effect described in clause (i)&nbsp;or (ii), a &#147;Material Adverse Effect&#148;). Except
for Moog Europe Holdings I LLC, a New York limited liability company, Moog Europe
Holdings II LLC, a New York limited liability company, AMC Delaware Inc. (f/k/a/ AMC
Controls, Inc), a Delaware corporation, X.O. Tec Corporation, a Delaware corporation,
Ethox International, Inc. a New York corporation, MMC Sterlization Services Group,
Inc., a Pennsylvania corporation, and Videolarm, Inc., a Georgia Corporation, the
Company owns or controls, directly or indirectly, only the corporations, partnerships,
limited liability partnerships, limited liability companies, associations or other
entities listed as subsidiaries of the Company in paragraph 21 of Section&nbsp;3 in Item&nbsp;15
of Part&nbsp;IV the Company&#146;s Annual Report on Form 10-K for the fiscal year ended September
27, 2008 filed with the Commission on November&nbsp;25, 2008, and the Company does not own
or control, directly or indirectly, any other interest in any other corporations,
partnerships,
limited liability partnerships, limited liability companies, associations or other
entities. Each such listed entity is a subsidiary of the Company and is wholly
owned, directly or indirectly, by the Company.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(i)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>This Agreement has been duly authorized, executed and delivered by the Company.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(j)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Stock to be issued and sold by the Company to the Underwriters hereunder
has been duly and validly authorized and, when issued and delivered against payment
therefor as provided herein, will be duly and validly issued, fully paid and
non-assessable, and free of any preemptive or similar rights and will conform to the
description thereof contained in the General Disclosure Package and the Prospectus.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(k)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company has an authorized capitalization as set forth in the Pricing
Prospectus, and all of the issued shares of capital stock of the Company, including the
Stock, have been duly and validly authorized and issued, are fully paid and
non-assessable, have been issued in compliance with federal and state securities laws
and conform to the description thereof contained in the Pricing Prospectus and the
Prospectus. None of the outstanding shares of common stock were issued in violation of
any preemptive rights, rights of first refusal or other similar rights to subscribe for
or purchase securities of the Company. There are no authorized or outstanding options,
warrants, preemptive rights, rights of first refusal or other rights to purchase, or
equity or debt securities convertible into or exchangeable or exercisable for, any
capital stock of the Company or any of its subsidiaries other than those accurately
described in the General Disclosure Package. The description of the Company&#146;s stock
option, stock bonus and other stock plans or arrangements, and the options or other
rights granted thereunder, set forth or incorporated by reference in the General
Disclosure Package accurately and fairly presents the information required to be shown
with respect to such plans, arrangements, options and rights under the Securities Act
and the Exchange Act. All of the Company&#146;s options, warrants and other rights to
purchase or exchange any securities for shares of the Company&#146;s capital stock have been
duly authorized and validly issued and were issued in compliance with federal and state
securities laws.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(l)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>All of the issued and outstanding capital stock of each subsidiary has been
duly authorized and validly issued, is fully paid and non-assessable and is owned by
the Company, directly or through subsidiaries, free and clear of any security interest,
mortgage, pledge, lien, encumbrance or claim (each, a &#147;Lien&#148;), except for the Liens
under the Second Amended and Restated Loan Agreement among certain lenders, HSBC Bank
USA, National Association, as administrative agent, and the Company dated as of October
25, 2006, as amended (the &#147;Loan Agreement&#148;).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(m)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Neither the Company nor any of its subsidiaries is in violation of its charter
or by-laws or is in default (or, with the giving of notice or lapse of time, would be
in
default) (&#147;Default&#148;) in the performance or observance of any obligation, agreement,
covenant or condition contained in any Existing Instruments (as defined below) or
any applicable law, administrative regulation or administrative or court order or
decree, except for such defaults as would not, individually or in </TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #textcolor#; background: #bgcolor#">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the aggregate,
result in a Material Adverse Effect. The execution, delivery and performance by the
Company of this Agreement, and the issuance and delivery of the Class&nbsp;A Common
Stock, and consummation of the transactions contemplated herein and therein and in
the General Disclosure Package have been duly authorized by all necessary corporate
action and will not conflict with or constitute a breach of, or a Default or a Debt
Repayment Triggering Event (as defined below) under, or the loss of any material
benefit under, or the termination of, or result in the creation or imposition of any
Lien upon any property or assets of the Company or any of its subsidiaries pursuant
to any contract, indenture, mortgage, loan agreement, note, lease, license or other
instrument to which the Company or any of its subsidiaries is a party or by which
any of them may be bound (including, without limitation, the Company&#146;s Loan
Agreement) or to which any of the property or assets of any of them is subject
(each, an &#147;Existing Instrument&#148;), except for such conflicts, breaches, Defaults,
losses or Liens as would not, individually or in the aggregate, result in a Material
Adverse Effect, nor will such action result in any violation of the provisions of
the charter or bylaws of the Company or any of its subsidiaries or any applicable
law, administrative regulation or administrative or court order or decree applicable
to the Company or any of its subsidiaries. As used herein, a &#147;Debt Repayment
Triggering Event&#148; means any event or condition which gives, or with the giving of
notice or lapse of time would give, the holder of any note, debenture or other
evidence of indebtedness (or any person acting on such holder&#146;s behalf) the right to
require the repurchase, redemption or repayment of all or a portion of such
indebtedness by the Company or any of its subsidiaries.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(n)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Except for the registration of the Stock under the Securities Act and such
consents, approvals, authorizations, registrations or qualifications as may be required
under the Exchange Act and applicable state securities laws and by the Financial
Industry Regulatory Authority (&#147;FINRA&#148;) in connection with the purchase and
distribution of the Stock by the Underwriters, no consent, approval, authorization or
order of, or filing, qualification or registration with, any court or governmental
agency or body, foreign or domestic, which has not been made, obtained or taken and is
not in full force and effect, is required for the execution, delivery and performance
of this Agreement by the Company, the offer or sale of the Stock or the consummation of
the transactions contemplated hereby.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(o)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Ernst &#038; Young LLP, who has expressed its opinion on the audited financial
statements and related schedules included or incorporated by reference in the
Registration Statement, General Disclosure Package, the Pricing Prospectus and the
Prospectus, is an independent registered public accounting firm as required by the
Securities Act and the Rules and Regulations and the Public Company Accounting
Oversight Board (United States) (the &#147;PCAOB&#148;) and has audited the
Company&#146;s internal control over financial reporting and management&#146;s assessment
thereof.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(p)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The financial statements, together with the related notes and schedules,
included or incorporated by reference in the General Disclosure Package, Pricing</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #textcolor#; background: #bgcolor#">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Prospectus, the Prospectus and the Registration Statement fairly present the financial
position and the results of operations and changes in financial position of the Company
and its consolidated subsidiaries and other consolidated entities at the respective
dates or for the respective periods therein specified. Such statements and related
notes and schedules have been prepared in accordance with generally accepted accounting
principles in the United States (&#147;GAAP&#148;) applied on a consistent basis throughout the
periods involved except as may be set forth in the General Disclosure Package, Pricing
Prospectus and the Prospectus. The financial statements, together with the related
notes and schedules, included or incorporated by reference in the General Disclosure
Package, Pricing Prospectus and the Prospectus comply in all material respects with the
Securities Act, the Exchange Act and the rules and regulations thereunder. No other
financial statements or supporting schedules or exhibits are required by the Securities
Act or the Rules and Regulations thereunder to be included in the General Disclosure
Package, Pricing Prospectus and the Prospectus. There is no pro forma or as adjusted
financial information which is required to be included in the Registration Statement,
the General Disclosure Package, the Prospectus or a document incorporated by reference
therein in accordance with Regulation&nbsp;S-X which has not been included or incorporated
as so required. The summary and selected financial data included or incorporated by
reference in the General Disclosure Package, the Pricing Prospectus, the Prospectus and
each Registration Statement fairly present the information shown therein as at the
respective dates and for the respective periods specified and are derived from the
consolidated financial statements set forth or incorporated by reference in the General
Disclosure Package, the Pricing Prospectus, the Prospectus and the Registration
Statement and other financial information.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(q)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Neither the Company nor any of its subsidiaries has sustained, since the date
of the latest audited financial statements included or incorporated by reference in the
General Disclosure Package, Pricing Prospectus and the Prospectus, any material loss or
interference with its business from fire, explosion, flood or other calamity, whether
or not covered by insurance, or from any labor dispute or court or governmental action,
order or decree, otherwise than as set forth or contemplated in the General Disclosure
Package, Pricing Prospectus and the Prospectus; and, since such date, there has not
been any change in the capital stock or long-term debt of the Company or any of its
subsidiaries or any material adverse change, or any development involving a prospective
material adverse change, in or affecting the business, general affairs, management,
financial position, prospects, stockholders&#146; equity or results of operations of the
Company and its subsidiaries taken as a whole, otherwise than as set forth or
contemplated in the General Disclosure Package, Pricing Prospectus and the Prospectus.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(r)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Except as set forth in the General Disclosure Package, Pricing Prospectus and
the Prospectus, there is no legal or governmental proceeding pending to which the
Company or any of its subsidiaries is a party or of which any property or assets of the
Company or any of its subsidiaries is the subject which, singularly or in the
aggregate, if determined adversely to the Company or any of its subsidiaries, </TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #textcolor#; background: #bgcolor#">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>might
have a Material Adverse Effect; and to the best of the Company&#146;s knowledge, no such
proceedings are threatened or contemplated by governmental authorities or threatened by
others.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(s)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company and each subsidiary possess such valid and current certificates,
authorizations or permits issued by the appropriate regulatory or other governmental
agencies or bodies as are necessary to conduct the business as now conducted by the
Company and its subsidiaries and as described in the General Disclosure Package and the
Prospectus, each such certificate, authorization and permit being in full force and
effect and the Company and each subsidiary is in compliance with the terms of each such
certificate, authorization and permit, except where the failure to possess or comply
with any such certificate, authorization or permit would not, individually or in the
aggregate, result in a Material Adverse Effect; and neither the Company nor any of its
subsidiaries has received any notice of proceedings relating to the revocation or
modification of, or non-compliance with, any such certificate, authorization or permit
which, individually or in the aggregate, if the subject of an unfavorable decision,
ruling or finding, would result in a Material Adverse Effect.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(t)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Neither the Company nor any of its subsidiaries is or, after giving effect to
the offering of the Stock and the application of the proceeds thereof as described in
the General Disclosure Package, Pricing Prospectus and the Prospectus will become, an
&#147;investment company&#148; within the meaning of the Investment Company Act of 1940, as
amended, and the rules and regulations of the Commission thereunder.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(u)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Neither the Company nor any of its officers, directors or affiliates has taken
or will take, directly or indirectly, any action designed or intended to stabilize or
manipulate the price of any security of the Company, or which caused or resulted in, or
which might in the future reasonably be expected to cause or result in, stabilization
or manipulation of the price of any security of the Company.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(v)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company and its subsidiaries own or possess sufficient trademarks, trade
names, patent rights, copyrights, licenses, approvals, trade secrets and other similar
rights (collectively, &#147;Intellectual Property Rights&#148;) reasonably necessary to conduct
their businesses as now conducted; and the expected expiration of any of such
Intellectual Property Rights would not result in a Material Adverse Effect. Neither
the Company nor any of its subsidiaries has received any notice of infringement or
conflict with asserted Intellectual Property Rights of others, which infringement or
conflict, if the subject of an unfavorable decision, would result in a Material Adverse
Effect.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(w)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company and each of its subsidiaries has good and marketable title to all
the properties and assets reflected as owned in the financial statements of the Company
and its consolidated subsidiaries free and clear of any Liens except for the Liens
under the Loan Agreement and except such as do not materially and adversely affect the
value of such property and do not materially interfere with the </TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #textcolor#; background: #bgcolor#">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>use made or proposed to
be made of such property by the Company or such subsidiary. The real property,
improvements, equipment and personal property held under lease by the Company or any
such subsidiary are held under valid and enforceable leases, with such exceptions as
are not material and do not materially interfere with the use made or proposed to be
made of such real property, improvements, equipment or personal property by the Company
or any of its subsidiaries.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(x)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>No strike, work stoppage or other similar labor dispute with the employees of
the Company or any of its subsidiaries, or, to the knowledge of the Company, with the
employees of any principal supplier of the Company or any of its subsidiaries, exists
or, to the knowledge of the Company or any of its subsidiaries, is threatened, which
would result in a Material Adverse Effect.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(y)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company and any of its subsidiaries and any &#147;employee benefit plan&#148; (as
defined under the Employee Retirement Income Security Act of 1974, as amended, and the
regulations and published interpretations thereunder (collectively, &#147;ERISA&#148;))
established or maintained by the Company or a subsidiary or any of their respective
&#147;ERISA Affiliates&#148; (as defined below) are and will be in compliance in all material
respects with ERISA. &#147;ERISA Affiliate&#148; means, with respect to the Company or such
subsidiary, any member of any group of organizations described in Section&nbsp;414(b), (c),
(m)&nbsp;or (o)&nbsp;of the Internal Revenue Code of 1986, as amended, and the regulations and
published interpretations thereunder (the &#147;Code&#148;) of which the Company or such
subsidiary is a member. No &#147;reportable event&#148; (as defined under Section&nbsp;4043 of ERISA
and for which notice has not been waived by applicable regulations) has occurred or is
reasonably expected to occur with respect to any &#147;employee benefit plan&#148; established or
maintained by the Company, its subsidiaries or any of their respective ERISA
Affiliates. No &#147;employee benefit plan&#148; established or maintained by the Company or any
of its subsidiaries or any of their respective ERISA Affiliates, if such &#147;employee
benefit plan&#148; were terminated, would have any &#147;amount of unfunded benefit liabilities&#148;
(as defined in Title IV of ERISA). None of the Company, its subsidiaries, or any of
their respective ERISA Affiliates has incurred or reasonably expects to incur any
liability under (i)&nbsp;Title I or IV of ERISA or (ii)&nbsp;Sections&nbsp;412, 4971, 4975 or 4980B of
the Code. Each &#147;employee benefit plan&#148; established or maintained by the Company or any
of its subsidiaries or any of their respective ERISA Affiliates that is intended to be
qualified under Section&nbsp;401 of the Code is and will be so qualified and nothing has
occurred, whether by action or failure to act, which would cause the loss of such
qualification.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(z)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Except as otherwise disclosed in the General Disclosure Package or as would
not, individually or in the aggregate, result in a Material Adverse Effect, as the case
may be, (i)&nbsp;neither the Company nor any of its subsidiaries is in violation of any
federal, state, local or foreign law or regulation relating to pollution or protection
of human health or the environment (including, without limitation, ambient air, surface
water, groundwater, land surface or subsurface strata) or wildlife, </TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #textcolor#; background: #bgcolor#">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>including, without
limitation, laws and regulations relating to emissions, discharges, releases or
threatened releases of chemicals, pollutants, contaminants, wastes, toxic substances,
hazardous substances, petroleum and petroleum products (collectively, &#147;Materials of
Environmental Concern&#148;), or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Materials of
Environmental Concern (collectively, &#147;Environmental Laws&#148;), which violation includes,
but is not limited to, noncompliance with any permits or other governmental
authorizations required for the operation of the business of the Company or its
subsidiaries under applicable Environmental Laws, or noncompliance with the terms and
conditions thereof, nor has the Company or any of its subsidiaries received any written
communication, whether from a governmental authority, citizens group, employee or
otherwise, that alleges that the Company or any of its subsidiaries is in violation of
any Environmental Law; (ii)&nbsp;there is no claim, action or cause of action filed with a
court or governmental authority, nor investigation with respect to which the Company or
any of its subsidiaries has received written notice, and no written notice by any
person or entity alleging potential liability for investigation costs, cleanup costs,
governmental responses costs, natural resources damages, property damages, personal
injuries, attorneys&#146; fees or penalties arising out of, based on or resulting from the
presence, or release into the environment, of any Material of Environmental Concern at
any location owned, leased or operated by the Company or any of its subsidiaries, now
or in the past (collectively, &#147;Environmental Claims&#148;), pending, or, to the best of the
Company&#146;s or any of its subsidiaries&#146; knowledge, threatened or contemplated against the
Company or any of its subsidiaries or any person or entity whose liability for any
Environmental Claim the Company or any of its subsidiaries has retained or assumed
either contractually or by operation of law; and (iii)&nbsp;to the best of the Company&#146;s
knowledge, there are no past or present actions, activities, circumstances, conditions,
events or incidents, including, without limitation, the release, emission, discharge,
presence or disposal of any Material of Environmental Concern, that reasonably could
result in a violation of any Environmental Law or form the basis of a potential
Environmental Claim against the Company or any of its subsidiaries or against any
person or entity whose liability for any Environmental Claim the Company or any of its
subsidiaries has retained or assumed either contractually or by operation of law. In
the ordinary course of business, the Company and each of its subsidiaries conducts a
periodic review of the effect of Environmental Laws on its respective business,
operations and properties, in the course of which they identify and evaluate associated
costs and liabilities (including, without limitation, any capital or operating
expenditures required for clean-up, closure of properties or compliance with
Environmental
Laws or any permit, license or approval, any related constraints on operating
activities and any potential liabilities to third parties). On the basis of such
review and the amount of its established reserves, the Company has reasonably
concluded that such associated costs and liabilities would not, individually or in
the aggregate, result in a Material Adverse Effect, except as otherwise disclosed in
the General Disclosure Package.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(aa)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>All necessary federal, state and foreign income and franchise tax returns
required to be filed by the Company and its consolidated subsidiaries have been filed,
other than those filings being contested in good faith, and all material taxes,
including withholding taxes, penalties and interest, assessments, fees and other
charges due or claimed to be due from such entities have been paid, other than those
being contested in good faith and for which adequate reserves have been provided or
those currently payable without penalty or interest. The Company has made adequate
charges, accruals and reserves in the applicable financial statements referred to in
Section 2(p) above in respect of all federal, state and foreign income and franchise
taxes for all periods as to which the tax liability of the Company or any of its
consolidated subsidiaries has not been finally determined.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(bb)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Each of the Company and its subsidiaries are insured by recognized, financially
sound institutions with policies in such amounts and with such deductibles and covering
such risks as are generally deemed adequate and customary for their businesses
including, but not limited to, policies covering real and personal property owned or
leased by the Company and its subsidiaries against theft, damage, destruction, acts of
vandalism and earthquakes. Except as disclosed in the General Disclosure Package, the
Company does not have any reason to believe that it or any subsidiary will not be able
(i)&nbsp;to renew its existing insurance coverage as and when such policies expire or (ii)
to obtain comparable coverage from similar institutions as may be necessary or
appropriate to conduct its business as now conducted and at a cost that would not
result in a Material Adverse Effect, as the case may be. Neither the Company nor any
subsidiary has been denied any insurance coverage that it has sought or for which it
has applied.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(cc)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Except as otherwise disclosed in the General Disclosure Package, the Company
maintains a system of accounting controls sufficient to provide reasonable assurances
that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific
authorization; (ii)&nbsp;transactions are recorded as necessary to permit preparation of
financial statements in conformity with generally accepted accounting principles and to
maintain accountability for assets; (iii)&nbsp;access to assets is permitted only in
accordance with management&#146;s general or specific authorization; and (iv)&nbsp;the recorded
accountability for assets is compared with existing assets at reasonable intervals and
appropriate action is taken with respect to any differences. The Company has
established and maintains disclosure controls and procedures (as such term is defined
in Rule&nbsp;13a-14 under the Exchange Act), which (i)&nbsp;are designed to ensure that material
information relating to the Company, including its consolidated subsidiaries, is made
known to the Company&#146;s principal executive officer and its principal financial officer
by others
within those entities, particularly during the periods in which the periodic reports
required under the Exchange Act are being prepared, (ii)&nbsp;have been evaluated for
effectiveness as of a date within 90&nbsp;days prior to the filing of the Company&#146;s most
recent annual or quarterly report filed with the Commission and (iii)&nbsp;are effective
in all material respects to perform the functions for which they were established.
Based on the evaluation of the Company&#146;s disclosure controls and procedures
described above, the Company is not aware of (a)&nbsp;any significant deficiency in the</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #textcolor#; background: #bgcolor#">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>design or operation of internal controls which could adversely affect the Company&#146;s
ability to record, process, summarize and report financial data or any material
weaknesses in internal controls or (b)&nbsp;any fraud, whether or not material, that
involves management or other employees who have a significant role in the Company&#146;s
internal controls. Since the most recent evaluation of the Company&#146;s disclosure
controls and procedures described above, there have been no significant changes in
internal controls or in other factors that could significantly affect internal
controls.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(dd)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The minute books of the Company and each of its subsidiaries have been made
available to the Underwriters and counsel for the Underwriters, and such books (i)
contain a complete summary of all meetings and actions of the board of directors
(including each board committee) and shareholders of the Company (or analogous
governing bodies and interest holders, as applicable), and each of its subsidiaries
since the time of its respective incorporation or organization through the date of the
latest meeting and action, and (ii)&nbsp;accurately in all material respects reflect all
transactions referred to in such minutes.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(ee)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>There is no franchise, lease, contract, agreement or document required by the
Securities Act or by the Rules and Regulations to be described in the Pricing
Prospectus and the Prospectus or a document incorporated by reference therein or to be
filed as an exhibit to the Registration Statement which is not described or filed
therein as required; and all descriptions of any such franchises, leases, contracts,
agreements or documents contained in the Registration Statement are accurate and
complete descriptions of such documents in all material respects. Other than as
described in the Pricing Prospectus and the Prospectus, no such franchise, lease,
contract or agreement has been suspended or terminated for convenience or default by
the Company or any of the other parties thereto, and neither the Company nor any of its
subsidiaries has received notice or has any other knowledge of any such pending or
threatened suspension or termination, except for such pending or threatened suspensions
or terminations that would not reasonably be expected to, singularly or in the
aggregate, have a Material Adverse Effect.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(ff)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>There are no business relationships or related-party transactions involving the
Company or any subsidiary or any other person required to be described in the General
Disclosure Package and Prospectus that have not been described as required.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(gg)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>No person or entity has the right to require registration of shares of Common
Stock or other securities of the Company or any of its subsidiaries because of the
filing or effectiveness of the Registration Statement or otherwise, except for persons
and entities who have expressly waived such right or who have been given timely and
proper notice and have failed to exercise such right within the time or times required
under the terms and conditions of such right.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(hh)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Neither the Company nor any of its subsidiaries owns any &#147;margin securities&#148; as
that term is defined in Regulation&nbsp;U of the Board of Governors of the Federal Reserve
System (the &#147;Federal Reserve Board&#148;), and none of the proceeds of the sale of the Stock
will be used, directly or indirectly, for the purpose of purchasing or carrying any
margin security, for the purpose of reducing or retiring any indebtedness which was
originally incurred to purchase or carry any margin security or for any other purpose
which might cause any of the Stock to be considered a &#147;purpose credit&#148; within the
meanings of Regulation&nbsp;T, U or X of the Federal Reserve Board.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(ii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Neither the Company nor any of its subsidiaries is a party to any contract,
agreement or understanding with any person that would give rise to a valid claim
against the Company or the Underwriters for a brokerage commission, finder&#146;s fee or
like payment in connection with the offering and sale of the Stock.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(jj)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>No forward-looking statement (within the meaning of Section&nbsp;27A of the
Securities Act and Section&nbsp;21E of the Exchange Act) contained in either the Pricing
Prospectus, the General Disclosure Package or the Prospectus has been made or
reaffirmed without a reasonable basis or has been disclosed other than in good faith.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(kk)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company is subject to and in compliance in all material respects with the
reporting requirements of Section&nbsp;13 or Section 15(d) of the Exchange Act. The Common
Stock is registered pursuant to Section 12(b) of the Exchange Act and is listed on the
New York Stock Exchange, and the Company has taken no action designed to, or reasonably
likely to have the effect of, terminating the registration of the Common Stock under
the Exchange Act or delisting the Common Stock from the New York Stock Exchange, nor
has the Company received any notification that the Commission or FINRA is contemplating
terminating such registration or listing.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(ll)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Stock has been approved for listing subject to official notice of issuance
on the New York Stock Exchange.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(mm)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company and, to the best of its knowledge, its officers and directors are
in compliance in all material respects with applicable provisions of the Sarbanes-Oxley
Act of 2002 and the rules and regulations promulgated in connection therewith that are
effective as of the date hereof.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(nn)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company is in compliance with all applicable corporate governance
requirements set forth in the New York Stock Exchange Rules that are then in effect and
is actively taking steps to ensure that it will be in compliance with other applicable
corporate governance requirements set forth in the New York Stock Exchange Rules not
currently in effect upon and all times after the effectiveness of such requirements.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(oo)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Neither the Company nor any of its subsidiaries nor, to the best of the
Company&#146;s knowledge, any employee or agent of the Company or any subsidiary has made
any contribution or other payment to any official of, or candidate for, any federal,
state, local or foreign office in violation of any law (including the Foreign Corrupt
Practices Act of 1977, as amended).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(pp)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>There are no transactions, arrangements or other relationships between and/or
among the Company, any of its affiliates (as such term is defined in Rule&nbsp;405 of the
Rules and Regulations) and any unconsolidated entity, including, but not limited to,
any structured finance, special purpose or limited purpose entity, that could
reasonably be expected to materially affect the Company&#146;s liquidity or the availability
of or requirements for its capital resources required to be described in the Pricing
Prospectus and the Prospectus which have not been described as required.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(qq)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The operations of the Company and its subsidiaries are and have been conducted
at all times in compliance with applicable financial recordkeeping and reporting
requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, applicable money laundering statutes and applicable rules and regulations
thereunder (collectively, the &#147;Money Laundering Laws&#148;), and no action, suit or
proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company or any of its subsidiaries with respect to the Money
Laundering Laws is pending, or to the best knowledge of the Company, threatened.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(rr)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Neither the Company nor any of its subsidiaries nor, to the knowledge of the
Company, any director, officer, agent, employee or affiliate of the Company or any of
its subsidiaries is currently subject to any U.S. sanctions administered by the Office
of Foreign Assets Control of the U.S. Treasury Department (&#147;OFAC&#148;); and the Company
will not directly or indirectly use the proceeds of the offering, or lend, contribute
or otherwise make available such proceeds to any subsidiary, joint venture partner or
other person or entity, for the purpose of financing the activities of any person
currently subject to any U.S. sanctions administered by OFAC.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(ss)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>There are no outstanding loans, advances (except normal advances for business
expenses in the ordinary course of business) or guarantees or indebtedness by the
Company or any of its subsidiaries to or for the benefit of (i)&nbsp;any of the officers or
directors of (A)&nbsp;the Company or (B)&nbsp;any of the Company&#146;s subsidiaries or (ii)&nbsp;any of
their respective family members, except as disclosed in the Registration
Statement, the Pricing Prospectus, the General Disclosure Package and the
Prospectus.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(tt)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Neither the Company nor any of its affiliates (within the meaning of NASD
Conduct Rule&nbsp;2720(b)(1)(a)) directly or indirectly controls, is controlled by, or is
under common control with, or is an associated person (within the meaning of</TD>
</TR>

</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->15<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Article&nbsp;I, Section&nbsp;1(ee) of the By-laws of FINRA) of, any member firm of FINRA.</TD>
</TR>

</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Any certificate signed by or on behalf of the Company and delivered to the Representative or to
counsel for the Underwriters shall be deemed to be a representation and warranty by the Company to
each Underwriter as to the matters covered thereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT style="font-variant: SMALL-CAPS"><I>3.&nbsp;Purchase, Sale and Delivery of Offered Securities</I></FONT>. On the basis of the representations,
warranties and agreements herein contained, but subject to the terms and conditions herein set
forth, the Company agrees to sell to each Underwriter, and each Underwriter agrees, severally and
not jointly, to purchase from the Company the respective numbers of shares of Firm Stock set forth
opposite the names of the Underwriters in Schedule&nbsp;A hereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The purchase price per share to be paid by the Underwriters to the Company for the Stock will
be $28.025 per share (the &#147;Purchase Price&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company will deliver the Firm Stock to the Representative for the respective accounts of
the several Underwriters (through the facilities of The Depository Trust Company issued in such
names and in such denominations as the Representative may direct by notice in writing to the
Company given at or prior to 12:00 Noon, New York time, on the second full business day preceding
the First Closing Date) against payment of the aggregate Purchase Price therefor by wire transfer
to an account designated by the Company, all at the offices of Shearman &#038; Sterling LLP, 599
Lexington Avenue, New York, New York 10022. Time shall be of the essence, and delivery at the time
and place specified pursuant to this Agreement is a further condition of the obligations of each
Underwriter hereunder. The time and date of the delivery and closing shall be at 10:00&nbsp;A.M., New
York time, on October&nbsp;2, 2009, in accordance with Rule&nbsp;15c6-1 of the Exchange Act. The time and
date of such payment and delivery are herein referred to as the &#147;First Closing Date&#148;. The First
Closing Date and the location of delivery of, and the form of payment for, the Firm Stock may be
varied by agreement between the Company and Cowen.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the purpose of covering any over-allotments in connection with the distribution and sale
of the Firm Stock as contemplated by the Prospectus, the Underwriters may purchase all or less than
all of the Optional Stock. The price per share to be paid for the Optional Stock shall be the
Purchase Price. The Company agrees to sell to the Underwriters the number of shares of Optional
Stock specified in the written notice by Cowen described below. Such shares of Optional Stock
shall be purchased from the Company for the account of each Underwriter in the same proportion as
the number of shares of Firm Stock set forth opposite such Underwriter&#146;s name on <U>Schedule&nbsp;A</U>
bears to the total number of shares of Firm Stock (subject to adjustment by Cowen to eliminate
fractions). The option granted hereby may be exercised as to all or any part of the Optional Stock
at any time, and from time to time, not more than thirty (30)&nbsp;days subsequent to the date of this
Agreement. No Optional Stock shall be sold and delivered unless the Firm Stock previously has
been, or simultaneously is, sold and delivered. The right to purchase the Optional Stock or any
portion thereof may be surrendered and terminated at any time upon notice by Cowen to the Company.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->16<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The option granted hereby may be exercised by written notice being given to the Company by
Cowen setting forth the number of shares of the Optional Stock to be purchased by the Underwriters
and the date and time for delivery of and payment for the Optional Stock. Each date and time for
delivery of and payment for the Optional Stock (which may be the First Closing Date, but not
earlier) is herein called the &#147;Option Closing Date&#148; and shall in no event be earlier than two (2)
business days nor later than five (5)&nbsp;business days after written notice is given. (The Option
Closing Date and the First Closing Date are herein called the &#147;Closing Dates&#148;.)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company will deliver the Optional Stock to the Representative for the respective accounts
of the several Underwriters (through the facilities of The Depository Trust Company issued in such
names and in such denominations as the Representative may direct by notice in writing to the
Company given at or prior to 12:00 Noon, New York time, on the second full business day preceding
the Option Closing Date) against payment of the aggregate Purchase Price therefor by wire transfer
in federal (same day) funds to an account designated by the Company all at the offices of Shearman
&#038; Sterling LLP, 599 Lexington Avenue, New York, New York 10022. Time shall be of the essence, and
delivery at the time and place specified pursuant to this Agreement is a further condition of the
obligations of each Underwriter hereunder. The Option Closing Date and the location of delivery
of, and the form of payment for, the Optional Stock may be varied by agreement between the Company
and Cowen.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The several Underwriters propose to offer the Stock for sale upon the terms and conditions set
forth in the Prospectus.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">4.<FONT style="font-variant: SMALL-CAPS"> <I>Further Agreements of the Company</I></FONT>. The Company agrees with the several Underwriters
that:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company will prepare the Prospectus in a form approved by the
Representative containing information previously omitted at the time of effectiveness
of the Registration Statement in reliance on rules 430A, 430B and 430C and to file such
Prospectus pursuant to Rule 424(b) under the Securities Act not later than the second
business day following the execution and delivery of this Agreement or, if applicable,
such earlier time as may be required by Rule&nbsp;430A of the Rules and Regulations; during
the period beginning on the Applicable Time and ending on the Option Closing Date, to
notify the Representative immediately of the Company&#146;s intention to file or prepare any
supplement or amendment to the Registration Statement or to the Prospectus and to make
no amendment or supplement to the Registration Statement, the General Disclosure
Package or the Prospectus to which the Representative shall reasonably object by notice
to the Company after a reasonable period to review; to advise the Representative,
promptly after it receives notice thereof, of the time when any amendment to any
Registration Statement has been filed or becomes effective or any supplement to the
General Disclosure Package or the Prospectus or any amended Prospectus has been filed
and to furnish the Underwriters with copies thereof; to file promptly all material
required to be filed by the Company with the Commission pursuant to Rule 433(d) or
163(b)(2), as the case may be; to file promptly all reports and any
definitive proxy or information statements required to be filed by the Company</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->17<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>with
the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act
subsequent to the date of the Prospectus and for so long as the delivery of a
prospectus (or in lieu thereof, the notice referred to in Rule 173(a) under the
Securities Act) is required in connection with the offering or sale of the Stock; to
advise the Representative, promptly after it receives notice thereof, of the
issuance by the Commission of any stop order or of any order preventing or
suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus
or the Prospectus, of the suspension of the qualification of the Stock for offering
or sale in any jurisdiction, of the initiation or threatening of any proceeding for
any such purpose, or of any request by the Commission for the amending or
supplementing of the Registration Statement, the General Disclosure Package or the
Prospectus or for additional information; and, in the event of the issuance of any
stop order or of any order preventing or suspending the use of any Preliminary
Prospectus, any Issuer Free Writing Prospectus or the Prospectus or suspending any
such qualification, will promptly to use its best efforts to obtain the withdrawal
of such order.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company represents and agrees that, unless it obtains the prior consent of
the Representative it has not and will not make any offer relating to the Stock that
would constitute a &#147;free writing prospectus&#148; as defined in Rule&nbsp;405 under the
Securities Act unless the prior written consent of the Representative has been received
(each, a &#147;Permitted Free Writing Prospectus&#148;); <I>provided </I>that the prior written consent
of the Representative hereto shall be deemed to have been given in respect of the
Issuer Free Writing Prospectuses included in <U>Schedule&nbsp;B</U> hereto. The Company
represents that it has treated and agrees that it will treat each Permitted Free
Writing Prospectus as an Issuer Free Writing Prospectus, comply with the requirements
of Rules&nbsp;164 and 433 of the Rules and Regulations applicable to any Issuer Free Writing
Prospectus, including the requirements relating to timely filing with the Commission,
legending and record keeping and will not take any action that would result in an
Underwriter or the Company being required to file with the Commission pursuant to Rule
433(d) of the Rules and Regulations a free writing prospectus prepared by or on behalf
of such Underwriter that such Underwriter otherwise would not have been required to
file thereunder. The Company consents to the use by any Underwriter of a free writing
prospectus that is not an &#147;issuer free writing prospectus&#148; as defined in Rule&nbsp;433 and
contains only information describing the preliminary terms of the Stock or this
offering.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If at any time prior to the expiration of nine (9)&nbsp;months after the later of
(i)&nbsp;the latest effective date of the Registration Statement or (ii)&nbsp;the date of the
Prospectus, when a prospectus relating to the Stock is required to be delivered (or in
lieu thereof, the notice referred to in Rule 173(a) of the Rules and Regulations) any
event occurs or condition exists as a result of which the Prospectus as then amended or
supplemented would include any untrue statement of a material fact, or omit to state
any material fact necessary to make the statements therein, in light of the
circumstances under which they were made when the Prospectus is
delivered (or in lieu thereof, the notice referred to in Rule 173(a) of the Rules
and</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->18<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Regulations), not misleading, or if it is necessary at any time to amend or
supplement the Registration Statement or the Prospectus or to file under the
Exchange Act any document incorporated by reference in the Prospectus to comply with
the Securities Act or the Exchange Act, that the Company will promptly notify the
Representative thereof and upon their request will prepare an appropriate amendment
or supplement or upon their request make an appropriate filing pursuant to Section
13 or 14 of the Exchange Act which will correct such statement or omission or effect
such compliance and will use its best efforts to have any such amendment declared
effective as soon as possible. The Company will furnish without charge to each
Underwriter and to any dealer in securities as many copies as the Representative may
from time to time reasonably request of such amendment or supplement. In case any
Underwriter is required to deliver a prospectus (or in lieu thereof, the notice
referred to in Rule 173(a) of the Rules and Regulations) relating to the Stock nine
(9)&nbsp;months or more after the later of (i)&nbsp;the latest effective date of the
Registration Statement or (ii)&nbsp;the date of the Prospectus, the Company upon the
request of the Representative and at the expense of such Underwriter will prepare
promptly an amended or supplemented Prospectus as may be necessary to permit
compliance with the requirements of Section&nbsp;10(a)(3) of the Securities Act.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If the General Disclosure Package is being used to solicit offers to buy the
Stock at a time when the Prospectus is not yet available to prospective purchasers and
any event shall occur as a result of which, in the judgment of the Company or in the
reasonable opinion of the Underwriters, it becomes necessary to amend or supplement the
General Disclosure Package in order to make the statements therein, in the light of the
circumstances then prevailing, not misleading, or to make the statements therein not
conflict with the information contained or incorporated by reference in the
Registration Statement then on file and not superseded or modified, or if it is
necessary at any time to amend or supplement the General Disclosure Package to comply
with any law, the Company promptly will either (i)&nbsp;prepare, file with the Commission
(if required) and furnish to the Underwriters and any dealers an appropriate amendment
or supplement to the General Disclosure Package or (ii)&nbsp;prepare and file with the
Commission an appropriate filing under the Exchange Act which shall be incorporated by
reference in the General Disclosure Package so that the General Disclosure Package as
so amended or supplemented will not, in the light of the circumstances then prevailing,
be misleading or conflict with the Registration Statement then on file, or so that the
General Disclosure Package will comply with law.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(e)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If at any time following issuance of an Issuer Free Writing Prospectus there
occurred or occurs an event or development as a result of which such Issuer Free
Writing Prospectus conflicted or will conflict with the information contained in the
Registration Statement, Pricing Prospectus or Prospectus, including any document
incorporated by reference therein and any prospectus supplement deemed to be a part
thereof and not superseded or modified or included, or would include an untrue
statement of a material fact or omitted or would omit to state a
material fact required to be stated therein or necessary in order to make the</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->19<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>statements therein, in the light of the circumstances prevailing at the subsequent
time, not misleading; the Company will promptly notify the Representative and will,
if requested by Cowen, promptly prepare and furnish, without charge, to each
Underwriter an Issuer Free Writing Prospectus which corrects such conflict, untrue
statement or omission.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(f)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To furnish promptly to each of the Representative and to counsel for the
Underwriters a signed copy of the Registration Statement as originally filed with the
Commission, and each amendment thereto filed with the Commission, including all
consents and exhibits filed therewith.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(g)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To deliver promptly to the Representative in New York City such number of the
following documents as the Representative shall reasonably request: (i)&nbsp;conformed
copies of the Registration Statement as originally filed with the Commission (in each
case excluding exhibits), (ii)&nbsp;each Preliminary Prospectus, if any, (iii)&nbsp;any Issuer
Free Writing Prospectus, (iv)&nbsp;the Prospectus (the delivery of the documents referred to
in clauses (i), (ii), (iii)&nbsp;and (iv)&nbsp;of this paragraph (g)&nbsp;to be made not later than
10:00&nbsp;A.M., New York time, on the second business day following the execution and
delivery of this Agreement), (v)&nbsp;conformed copies of any amendment to the Registration
Statement (excluding exhibits), (vi)&nbsp;any amendment or supplement to the General
Disclosure Package or the Prospectus (the delivery of the documents referred to in
clauses (v)&nbsp;and (vi)&nbsp;of this paragraph (g)&nbsp;to be made not later than 10:00&nbsp;A.M., New
York City time, on the business day following the date of such amendment or supplement)
and (vii)&nbsp;any document incorporated by reference in the General Disclosure Package or
the Prospectus (excluding exhibits thereto) (the delivery of the documents referred to
in clause (vii)&nbsp;of this paragraph (g)&nbsp;to be made not later than 10:00&nbsp;A.M., New York
City time, on the business day following the date of any such document).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(h)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To make generally available to its shareholders as soon as practicable, but in
any event not later than eighteen months after the effective date of the Registration
Statement (as defined in Rule 158(c) under the Securities Act), an earnings statement
of the Company and its subsidiaries (which need not be audited) complying with Section
11(a) of the Securities Act and the Rules and Regulations (including, at the option of
the Company, Rule&nbsp;158).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(i)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company will promptly take from time to time such actions as the
Representative may reasonably request to qualify the Stock for offering and sale under
the securities or Blue Sky laws of such jurisdictions as the Representative may
designate and to continue such qualifications in effect for so long as required for the
distribution of the Stock; <I>provided </I>that the Company and its subsidiaries shall not be
obligated to qualify as foreign corporations in any jurisdiction in which they are not
so qualified or to file a general consent to service of process in any jurisdiction.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(j)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>During the period of five years from the date hereof, the Company will deliver
to the Representative and, upon request, to each of the other Underwriters, (i)&nbsp;as</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->20<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>soon
as they are available, copies of all reports or other communications furnished to
shareholders and (ii)&nbsp;as soon as they are available, copies of any reports and
financial statements furnished or filed with the Commission pursuant to the Exchange
Act or any national securities exchange or automatic quotation system on which the
Stock is listed or quoted. The EDGAR filing or furnishing of any such report,
communication or financial statement with the Commission under Section&nbsp;13(a), 13(c), 14
or 15(d) of the Exchange Act shall be deemed to satisfy the requirement to deliver such
report, communication or financial statement to the Representative or Underwriters.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(k)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company will not directly or indirectly offer, sell, assign, transfer,
pledge, contract to sell, or otherwise dispose of any shares of Common Stock or
securities convertible into or exercisable or exchangeable for Common Stock for a
period of 90&nbsp;days from the date of the Prospectus without the prior written consent of
Cowen other than the Company&#146;s sale of the Stock hereunder and the issuance of shares
pursuant to employee benefit plans, qualified stock option plans or other employee
compensation plans existing on the date hereof or pursuant to currently outstanding
options, warrants or rights. The Company will cause each officer, director and
shareholder listed in <U>Schedule&nbsp;C</U> to furnish to the Representative, prior to the
First Closing Date, a letter, substantially in the form of <U>Exhibit&nbsp;I</U> hereto,
pursuant to which each such person shall agree not to directly or indirectly offer,
sell, assign, transfer, pledge, contract to sell, or otherwise dispose of any shares of
Common Stock or securities convertible into or exercisable or exchangeable for Common
Stock for a period of 90&nbsp;days from the date of the Prospectus (the &#147;Lock-Up Period&#148;),
without the prior written consent of Cowen. The Company also agrees that during such
Lock-Up Period, the Company will not file any registration statement, preliminary
prospectus or prospectus, or any amendment or supplement thereto, under the Securities
Act for any such transaction or which registers, or offers for sale, Common Stock or
any securities convertible into or exercisable or exchangeable for Common Stock, except
for a registration statement on Form S-8 relating to employee benefit plans. The
Company hereby agrees that (i)&nbsp;if it issues an earnings release or material news or if
a material event relating to the Company occurs during the last seventeen days of the
Lock-Up Period, or (ii)&nbsp;if prior to the expiration of the Lock-Up Period, the Company
announces that it will release earnings results during the sixteen day period beginning
on the last day of the Lock-Up Period, the restrictions imposed by this paragraph (k)
or the letter shall continue to apply until the expiration of the eighteen day period
beginning on the issuance of the earnings release or the occurrence of the material
news or the material event.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(l)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company will supply the Representative with copies of all correspondence to
and from, and all documents issued to and by, the Commission in connection with the
registration of the Stock under the Securities Act or the Registration Statement, any
Preliminary Prospectus, if any, or the Prospectus, or any amendment or supplement
thereto or document incorporated by reference therein.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->21<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(m)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Prior to each of the Closing Dates, the Company will furnish to the
Representative, as soon as they have been prepared, copies of any unaudited interim
consolidated financial statements of the Company for any periods subsequent to the
periods covered by the financial statements appearing in the Registration Statement and
the Prospectus.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(n)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Prior to each of the Closing Dates, the Company will not issue any press
release or other communication directly or indirectly or hold any press conference with
respect to the Company, its condition, financial or otherwise, or earnings, business
affairs or business prospects (except for routine oral marketing communications in the
ordinary course of business and consistent with the past practices of the Company and
of which the Representative is notified), without the prior written consent of the
Representative, unless in the judgment of the Company and its counsel, and after
notification to the Representative, such press release or communication is required by
law.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(o)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>In connection with the offering of the Stock, until Cowen shall have notified
the Company of the completion of the resale of the Stock, the Company will not, and
will cause its affiliated purchasers (as defined in Regulation&nbsp;M under the Exchange
Act) not to, either alone or with one or more other persons, bid for or purchase, for
any account in which it or any of its affiliated purchasers has a beneficial interest,
any Common Stock, or attempt to induce any person to purchase any Common Stock; and not
to, and to cause its affiliated purchasers not to, make bids or purchase for the
purpose of creating actual, or apparent, active trading in or of raising the price of
the Common Stock.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(p)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company will not take any action prior to the Option Closing Date which
would require the Prospectus to be amended or supplemented pursuant to Section&nbsp;4(c).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(q)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company shall at all times comply with all applicable provisions of the
Sarbanes-Oxley Act in effect from time to time.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(r)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To apply the net proceeds from the sale of the Stock as set forth in the
Registration Statement, the General Disclosure Package and the Prospectus under the
heading &#147;Use of Proceeds.&#148;</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(s)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company shall at all times engage and maintain, at its expense, a registrar
and transfer agent for the Stock.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(t)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To pay the required Commission filing fees relating to the Stock within the
time required by Rule&nbsp;456(b)(1) under the Securities Act without regard to the proviso
therein and otherwise in accordance with Rules 456(b) and 457(r) under the Securities
Act.</TD>
</TR>

</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">5. <FONT style="font-variant: SMALL-CAPS"><I>Payment of Expenses</I></FONT>. The Company agrees with the Underwriters to pay (a)&nbsp;the costs incident to the authorization,
issuance, sale, preparation and delivery of the Stock and any taxes payable in that connection; (b)
the costs incident to the registration of the Stock under the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->22<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Securities Act; (c)&nbsp;the costs
incident to the preparation, printing and distribution of the Registration Statement, the Base
Prospectus, any Preliminary Prospectus, any Issuer Free Writing Prospectus, the General Disclosure
Package, the Prospectus, any amendments, supplements and exhibits thereto or any document
incorporated by reference therein, and the costs of printing, reproducing and distributing the
&#147;Agreement Among Underwriters&#148; between the Representative and the Underwriters, the Master Selected
Dealers&#146; Agreement, the Underwriters&#146; Questionnaire and this Agreement and any closing documents by
mail, telex or other means of communications; (d)&nbsp;the fees and expenses (including related fees and
expenses of counsel for the Underwriters) incurred in connection with securing any required review
by FINRA of the terms of the sale of the Stock and any filings made with FINRA; (e)&nbsp;any applicable
listing, quotation or other fees; (f)&nbsp;the fees and expenses (including related fees and expenses of
counsel to the Underwriters) of qualifying the Stock under the securities laws of the several
jurisdictions as provided in Section&nbsp;4 and of preparing, printing and distributing wrappers, Blue
Sky Memoranda and Legal Investment Surveys; (g)&nbsp;all fees and expenses of the registrar and transfer
agent of the Stock; and (h)&nbsp;all other costs and expenses incident to the performance of the
obligations of the Company under this Agreement (including, without limitation, the fees and
expenses of the Company&#146;s counsel and the Company&#146;s independent accountants); <I>provided </I>that, except
as otherwise provided in this Section&nbsp;5 and in Section&nbsp;9, the Underwriters shall pay their own
costs and expenses, including the fees and expenses of their counsel, any transfer taxes on the
Stock which they may sell and the expenses of advertising any offering of the Stock made by the
Underwriters.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">6.&nbsp;<FONT style="font-variant: SMALL-CAPS"><I>Conditions of Underwriters&#146; Obligations</I></FONT>. The respective obligations of the several
Underwriters hereunder are subject to the accuracy, when made and on each of the Applicable Time
and on each Closing Date, of the representations and warranties of the Company contained herein, to
the accuracy of the statements of the Company made in any certificates pursuant to the provisions
hereof, to the performance by the Company of its obligations hereunder, and to each of the
following additional terms and conditions:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>No stop order suspending the effectiveness of the Registration Statement or any
part thereof, preventing or suspending the use of any Base Prospectus, any Preliminary
Prospectus, the Prospectus or any Permitted Free Writing Prospectus or any part thereof
shall have been issued and no proceedings for that purpose shall have been initiated or
threatened by the Commission, and no notice of objection of the Commission to the use
of the Registration Statement or any post-effective amendment thereto pursuant to Rule
401(g)(2) of the Rules and Regulations shall have been received, and all requests for
additional information on the part of the Commission (to be included or incorporated by
reference in the Registration Statement or the Prospectus or otherwise) shall have been
complied with to the reasonable satisfaction of the Representative; the Rule 462(b)
Registration Statement, if any, each Issuer Free Writing Prospectus and the Prospectus
shall have been filed with the Commission within the applicable time period prescribed
for such filing by, and in compliance with, the Rules and
Regulations and in accordance with Section&nbsp;4(a), and FINRA shall have raised no
objection to the fairness and reasonableness of the terms of this Agreement or the
transactions contemplated hereby.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->23<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>None of the Underwriters shall have discovered and disclosed to the Company on
or prior to any Closing Date that the Registration Statement or the Prospectus or any
amendment or supplement thereto contains an untrue statement of a fact which, in the
opinion of counsel for the Underwriters, is material or omits to state any fact which,
in the opinion of such counsel, is material and is required to be stated therein or is
necessary to make the statements therein not misleading, or that the Pricing
Prospectus, the General Disclosure Package, any Issuer Free Writing Prospectus or the
Prospectus or any amendment or supplement thereto contains an untrue statement of fact
which, in the opinion of such counsel, is material or omits to state any fact which, in
the opinion of such counsel, is material and is necessary in order to make the
statements, in the light of the circumstances in which they were made, not misleading.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>All corporate proceedings and other legal matters incident to the
authorization, form and validity of each of this Agreement, the Stock, the Registration
Statement, the Pricing Prospectus, the General Disclosure Package, each Issuer Free
Writing Prospectus and the Prospectus and all other legal matters relating to this
Agreement and the transactions contemplated hereby shall be reasonably satisfactory in
all material respects to counsel for the Underwriters, and the Company shall have
furnished to such counsel all documents and information that they may reasonably
request to enable them to pass upon such matters.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>On each of the Closing Dates, Hodgson Russ LLP shall have furnished to the
Representative such counsel&#146;s written opinion, as counsel to the Company, addressed to
the Underwriters and dated such Closing Date, in form and substance reasonably
satisfactory to the Representative, to the effect that:</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(i)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company and each of its U.S. subsidiaries have been duly
incorporated and are validly existing as corporations in good standing under
the laws of their respective jurisdictions of incorporation, are to such
counsel&#146;s knowledge duly qualified to do business and are in good standing as
foreign corporations in each jurisdiction in which their respective ownership
or lease of property or the conduct of their respective businesses requires
such qualification, and have all power and authority necessary to own or hold
their respective properties and to conduct the businesses in which they are
engaged, except where the failure to so qualify or have such power or authority
would not have, singularly or in the aggregate, a Material Adverse Effect.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(ii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company has an authorized capitalization as set forth in
the General Disclosure Package and the Prospectus, and all of the issued shares
of capital stock of the Company, including the Stock being delivered on any
Closing Date, have been duly and validly authorized and issued, are fully
paid and non-assessable and conform to the description thereof contained in
the General Disclosure Package and the Prospectus.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->24<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(iii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>All the outstanding shares of capital stock of each U.S.
subsidiary of the Company have been duly authorized and validly issued, are
fully paid and non-assessable and, except to the extent set forth in the
General Disclosure Package and the Prospectus, are owned by the Company
directly or indirectly through one or more wholly owned subsidiaries, free and
clear of any claim, lien, encumbrance, security interest, restriction upon
voting or transfer or any other claim of any third party.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(iv)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>There are no preemptive or other rights to subscribe for or to
purchase, nor any restriction upon the voting or transfer of, any shares of the
Stock pursuant to the Company&#146;s charter or by-laws or any agreement or other
agreement or instrument listed as an exhibit to the Registration Statement or
to a document filed by the Company pursuant to the Exchange Act and
incorporated by reference into the Prospectus as of the date specified therein.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(v)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>This Agreement has been duly authorized, executed and delivered
by the Company.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(vi)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The execution, delivery and performance of this Agreement and
the consummation of the transactions contemplated hereby, including the
application of proceeds of the offering of Stock as described in &#147;Use of
Proceeds&#148; in the Pricing Prospectus, will not conflict with or result in a
breach or violation of any of the terms or provisions of, or constitute a
default under, any indenture, mortgage, deed of trust, loan agreement or other
agreement or instrument listed as an exhibit to the Registration Statement or
to a document filed by the Company pursuant to the Exchange Act and
incorporated by reference into the Prospectus as of the date specified therein,
nor will such actions result in any violation of the charter or by-laws of the
Company or of any of its U.S. subsidiaries or any statute or any order, rule or
regulation of any court or governmental agency or body or court having
jurisdiction over the Company or any of its subsidiaries or any of their
properties or assets.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(vii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Except for the registration of the Stock under the Securities
Act and such consents, approvals, authorizations, registrations or
qualifications as may be required under the Exchange Act and applicable state
securities laws in connection with the purchase and distribution of the Stock
by the Underwriters, no consent, approval, authorization or order of, or
filing, qualification or registration with, any court or governmental agency or
body, which has not been obtained or taken and is not in full force and effect,
is required for the execution, delivery and performance of this Agreement by
the Company, the offer, issue and sale of the Stock or the consummation by the
Company of the transactions contemplated hereby.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(viii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The statements in the General Disclosure Package and the Prospectus under the
heading &#147;Description of Capital Stock&#148; and &#147;Certain U.S.</TD>
</TR>


</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->25<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Federal Income and
Estate Tax Considerations for Non-U.S. Holders&#148;, to the extent that they
constitute summaries of matters of law or regulation or legal conclusions, have
been reviewed by such counsel and fairly summarize the matters described
therein in all material respects.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(ix)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To such counsel&#146;s knowledge, the description in the
Registration Statement, the General Disclosure Package and the Prospectus of
statutes, legal or governmental proceedings and contracts and other documents
are accurate in all material respects; and to the best of such counsel&#146;s
knowledge, there are no pending legal or governmental proceedings, or contracts
or other documents to which the Company or any of its subsidiaries is a party
or to which the property of the Company or any of its subsidiaries is subject
that are required to be described in the General Disclosure Package or the
Prospectus or to be filed as exhibits to the Registration Statement which are
not described or filed as required.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(x)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To such counsel&#146;s knowledge, neither the Company nor any of its
U.S. subsidiaries is in violation of its charter or by-laws.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(xi)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To such counsel&#146;s knowledge, neither the Company nor any of its
subsidiaries (i)&nbsp;is in default, and no event has occurred, which, with notice
or lapse of time or both, would constitute a default, in the due performance or
observance of any term, covenant or condition contained in any agreement or
instrument to which it is a party or by which it is bound or to which any of
its properties or assets is subject or (ii)&nbsp;is in violation of any law,
statute, ordinance, governmental rule, regulation or court decree to which it
or its property or assets may be subject or has failed to obtain any license,
permit, certificate, franchise or other governmental authorization or permit
necessary to the ownership of its property or to the conduct of its business as
described in the General Disclosure Package and the Prospectus except for those
defaults, violations or failures which, either individually or in the
aggregate, would not have a Material Adverse Effect.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(xii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To such counsel&#146;s knowledge and other than as set forth in the
General Disclosure Package and Prospectus, there are no legal or governmental
proceedings pending to which the Company or any of its subsidiaries is a party
or of which any property or asset of the Company or any of its subsidiaries is
the subject which, singularly or in the aggregate, if determined adversely to
the Company or any of its subsidiaries, might have a Material Adverse Effect or
would prevent or adversely affect the ability of the Company to perform its
obligations under this Agreement; and, to the best of such counsel&#146;s knowledge,
no such proceedings are threatened or contemplated by governmental authorities
or threatened by others.</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->26<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(xiii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Registration Statement and each post-effective amendment thereto was
declared effective under the Securities Act as of the date and time specified
in such opinion, the Prospectus was filed with the Commission pursuant to the
subparagraph of Rule 424(b) and in compliance with Rules&nbsp;430A and 430B of the
Rules and Regulations specified in such opinion on the date specified therein
and no stop order suspending the effectiveness of the Registration Statement
has been issued and, to the knowledge of such counsel, no proceeding for that
purpose is pending or threatened by the Commission.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(xiv)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Registration Statement and any amendments thereto made by
the Company prior to such Closing Date (other than the financial statements and
other financial data contained therein, as to which such counsel need express
no opinion), at the Applicable Time, complied as to form in all material
respects with the requirements of the Securities Act and the Rules and
Regulations; the Pricing Prospectus (other than the financial statements and
other financial data contained therein, as to which such counsel need express
no opinion), as of the Applicable Time, complied as to form in all material
respects with the requirements of the Securities Act; and the Prospectus and
any amendments or supplements thereto, as of their respective dates, made by
the Company prior to such Closing Date (other than the financial statements and
other financial data contained therein, as to which such counsel need express
no opinion) complied as to form in all material respects with the requirements
of the Securities Act and the Rules and Regulations; and the documents
incorporated by reference in the Pricing Prospectus and the Prospectus (other
than the financial statements and related schedules therein, as to which such
counsel need express no opinion), when they were filed with the Commission,
complied as to form in all material respects with the requirements of the
Securities Act and the Rules and Regulations.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(xv)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company meets the requirements for the use of Form S-3
under the Securities Act and the Rules and Regulations. The Registration
Statement and any post-effective amendment thereto meets the requirements set
forth in Rule&nbsp;415(a)(1)(x) of the Rules and Regulations.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(xvi)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>To such counsel&#146;s knowledge, no person or entity has the right
to require registration of shares of Common Stock or other securities of the
Company because of the filing or effectiveness of the Registration Statement or
otherwise, except for persons and entities who have expressly waived such right
or who have been given proper notice and have failed to exercise such right
within the time or times required under the terms and conditions of such right.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(xvii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company is not, and after giving effect to the offering and sale of the
Stock and the application of the proceeds thereof as described in the General
Disclosure Package and the Prospectus will not be, an</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->27<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>&#147;investment company&#148; within the meaning of such term as defined in the
Investment Company Act and the rules and regulations of the Commission
thereunder.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(xviii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Any required filing of each Issuer Free Writing Prospectus pursuant to Rule
433 under the Securities Act has been made within the time period required by
Rule 433(d) under the Securities Act.</TD>
</TR>

</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Such counsel shall also have furnished to the Representative a written
statement, addressed to the Underwriters and dated each Closing Date, in form and
substance satisfactory to the Representative, to the effect that (x)&nbsp;such counsel
has acted as counsel to the Company in connection with the preparation of the
Registration Statement, the Pricing Prospectus, the General Disclosure Package and
the Prospectus, and each amendment or supplement thereto made by the Company prior
to such Closing Date, (y)&nbsp;based on such counsel&#146;s examination of the Registration
Statement, the Pricing Prospectus, the General Disclosure Package and the
Prospectus, and each amendment or supplement thereto made by the Company prior to
such Closing Date and the documents incorporated by reference in the Pricing
Prospectus, the General Disclosure Package or the Prospectus and any further
amendment or supplement to any such incorporated document made by the Company prior
to such Closing Date, and such counsel&#146;s investigations made in connection with the
preparation of the Registration Statement, the Pricing Prospectus, the General
Disclosure Package and the Prospectus, and each amendment or supplement thereto made
by the Company prior to such Closing Date, and conferences with certain officers and
employees of and with auditors for and counsel to the Company, such counsel has no
reason to believe that the Registration Statement or any amendment thereto prior to
the Applicable Time, at the Applicable Time contained any untrue statement of a
material fact or omitted to state any material fact required to be stated therein or
necessary in order to make the statements therein not misleading, or that the
Prospectus or any amendment or supplement thereto, at the respective date thereof or
at such Closing Date, contained or contains any untrue statement of a material fact
or omits to state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not
misleading, or that the documents included in the General Disclosure Package all
considered together, as of the Applicable Time, contained or contains any untrue
statement of a material fact or omits to state any material fact necessary in order
to make the statements therein, in the light of the circumstances under which they
were made, not misleading, or (z)&nbsp;any document incorporated by reference in the
Prospectus, when they were filed with the Commission contained, in the case of a
registration statement which became effective under the Securities Act, any untrue
statement of a material fact or omitted to state any material fact required to be
stated therein or necessary in order to make the statements therein not misleading,
or, in the case of other documents which were filed under the Exchange Act with the
Commission, any untrue statement of a material fact or omitted to state any material
fact necessary in order to make the statements therein, in light of the
circumstances under which they were made, not
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->28<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">misleading; it being understood that such counsel need express no opinion as to
the financial statements or other financial data contained in the Registration
Statement, the General Disclosure Package or the Prospectus or an incorporated
document.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The foregoing opinion and statement may be qualified by a statement to the
effect that such counsel has not independently verified the accuracy, completeness
or fairness of the statements contained in the Registration Statement or the
Prospectus and takes no responsibility therefor except to the extent set forth in
the opinion described in clauses (viii)&nbsp;and (ix)&nbsp;above.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(e)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Representative shall have received from Shearman &#038; Sterling LLP, counsel
for the Underwriters, such opinion or opinions, dated each Closing Date, with respect
to such matters as the Underwriters may reasonably require, and the Company shall have
furnished to such counsel such documents as they request for enabling them to pass upon
such matters.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(f)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>At the time of the execution of this Agreement, the Representative shall have
received from Ernst &#038; Young LLP a letter, addressed to the Underwriters, executed and
dated such date, in form and substance satisfactory to the Representative, (i)
confirming that they are an independent registered accounting firm with respect to the
Company and its subsidiaries within the meaning of the Securities Act and the Rules and
Regulations and the PCAOB and stating the conclusions and findings of such firm, of the
type ordinarily included in accountants&#146; &#147;comfort letters&#148; to underwriters, with
respect to the financial statements and certain financial information contained or
incorporated by reference in the Registration Statement, the General Disclosure Package
and the Pricing Prospectus.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(g)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>On the effective date of any post-effective amendment to any Registration
Statement and on each Option Closing Date, the Representative shall have received a
letter (the &#147;bring-down letter&#148;) from Ernst &#038; Young LLP addressed to the Underwriters
and dated the Option Closing Date confirming, as of the date of the bring-down letter
(or, with respect to matters involving changes or developments since the respective
dates as of which specified financial information is given in the General Disclosure
Package and the Prospectus, as the case may be, as of a date not more than three
business days prior to the date of the bring-down letter), the conclusions and findings
of such firm with respect to the financial information and other matters covered by its
letter delivered to the Representative concurrently with the execution of this
Agreement pursuant to Section&nbsp;6(f).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(h)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company shall have furnished to the Representative a certificate, dated
such Date, of its Chairman of the Board, its President or a Vice President and its
chief financial officer stating that (i)&nbsp;such officers have carefully examined the
Registration Statement, the Pricing Prospectus, the General Disclosure Package, the
Prospectus and any Permitted Free Writing Prospectus; and in their opinion,</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->29<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the Registration Statement and each amendment thereto, if any, at the Applicable
Time and as of such Closing Date did not include any untrue statement of a material
fact and did not omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading; and the General Disclosure
Package, as of the Applicable Time and as of such Closing Date, any Permitted Free
Writing Prospectus as of its date and as of such Closing Date, the Prospectus and
each amendment or supplement thereto, as of the respective date thereof and as of
such Closing Date, did not include any untrue statement of a material fact and did
not omit to state a material fact necessary in order to make the statements therein,
in light of the circumstances in which they were made, not misleading, (ii)&nbsp;since
the effective date of the Registration Statement no event has occurred which should
have been set forth in a supplement or amendment to the Registration Statement, the
General Disclosure Package or the Prospectus, (iii)&nbsp;to the best of their knowledge
after reasonable investigation, as of such Closing Date, the representations and
warranties of the Company in this Agreement are true and correct and the Company has
complied with all agreements and satisfied all conditions on its part to be
performed or satisfied hereunder at or prior to such Closing Date, and (iv)&nbsp;there
has not been, subsequent to the date of the most recent audited financial statements
included or incorporated by reference in the General Disclosure Package, any
material adverse change in the financial position or results of operation of the
Company and its subsidiaries, or any change, or any development that, singularly or
in the aggregate, would involve a material adverse change or a prospective material
adverse change in or affecting the condition (financial or otherwise), results of
operations, business, assets or prospects of the Company and its subsidiaries taken
as a whole, except as set forth in the Prospectus.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(i)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>(i)&nbsp;Neither the Company nor any of its subsidiaries shall have sustained since
the date of the latest audited financial statements included in the General Disclosure
Package or incorporated by reference in the General Disclosure Package any loss or
interference with its business from fire, explosion, flood or other calamity, whether
or not covered by insurance, or from any labor dispute or court or governmental action,
order or decree, otherwise than as set forth or contemplated in the General Disclosure
Package and (ii)&nbsp;since such date there shall not have been any change in the capital
stock or long-term debt of the Company or any of its subsidiaries or any change, or any
development involving a prospective change, in or affecting the business, general
affairs, management, financial position, stockholders&#146; equity or results of operations
of the Company and its subsidiaries, otherwise than as set forth or contemplated in the
General Disclosure Package, the effect of which, in any such case described in clause
(i)&nbsp;or (ii), is, in the judgment of the Representative, so material and adverse as to
make it impracticable or inadvisable to proceed with the sale or delivery of the Stock
on the terms and in the manner contemplated in the General Disclosure Package.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(j)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>No action shall have been taken and no law, statute, rule, regulation or order
shall have been enacted, adopted or issued by any governmental agency or body which
would, as of any Closing Date, prevent the issuance or sale of the Stock or</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->30<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>materially and adversely affect or potentially materially and adversely affect the
business or operations of the Company; and no injunction, restraining order or order
of any other nature by any federal or state court of competent jurisdiction shall
have been issued as of the Closing Date which would prevent the issuance or sale of
the Stock or materially and adversely affect or potentially materially and adversely
affect the business or operations of the Company.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(k)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Subsequent to the execution and delivery of this Agreement (i)&nbsp;no downgrading
shall have occurred in the Company&#146;s corporate credit rating or the rating accorded the
Company&#146;s debt securities by any &#147;nationally recognized statistical rating
organization&#148;, as that term is defined by the Commission for purposes of Rule&nbsp;436(g)(2)
of the Rules and Regulations and (ii)&nbsp;no such organization shall have publicly
announced that it has under surveillance or review (other than an announcement with
positive implications of a possible upgrading) its rating of any of the Company&#146;s debt
securities.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(l)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Subsequent to the execution and delivery of this Agreement there shall not have
occurred any of the following: (i)&nbsp;trading in securities generally on the New York
Stock Exchange, Nasdaq Global Market or the American Stock Exchange or in the
over-the-counter market, or trading in any securities of the Company on any exchange or
in the over-the-counter market, shall have been suspended or materially limited or
minimum or maximum prices or maximum range for prices shall have been established on
any such exchange or such market by the Commission, by such exchange or market or by
any other regulatory body or governmental authority having jurisdiction, (ii)&nbsp;a banking
moratorium shall have been declared by federal or state authorities or a material
disruption has occurred in commercial banking or securities settlement or clearance
services in the United States, (iii)&nbsp;the United States shall have become engaged in
hostilities, or the subject of an act of terrorism, or there shall have been an
outbreak or an escalation in hostilities involving the United States or there shall
have been a declaration of a national emergency or war by the United States, or (iv)
there shall have occurred such a material adverse change in general economic, political
or financial conditions (or the effect of international conditions on the financial
markets in the United States shall be such) as to make it, in the judgment of the
Representative, impracticable or inadvisable to proceed with the sale or delivery of
the Stock on the terms and in the manner contemplated in the General Disclosure Package
or the Prospectus.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(m)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The New York Stock Exchange, Inc. shall have approved the Stock for listing,
subject only to official notice of issuance.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(n)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Cowen shall have received the written agreements, substantially in the form of
<U>Exhibit&nbsp;I</U> hereto, of the persons listed in <U>Schedule&nbsp;C</U> to this
Agreement.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All opinions, letters, evidence and certificates mentioned above or elsewhere in this
Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form
and substance reasonably satisfactory to counsel for the Underwriters.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->31<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><I>7. </I><FONT style="font-variant: SMALL-CAPS"><I>Indemnification and Contribution.</I></FONT>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company shall indemnify and hold harmless each Underwriter, its directors,
officers, employees, representatives and agents and each person, if any, who controls
any Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of
the Exchange Act (collectively, the &#147;Underwriter Indemnified Parties&#148; and each, an
&#147;Underwriter Indemnified Party&#148;) against any loss, claim, damage, expense or liability
whatsoever (or any action, investigation or proceeding in respect thereof), joint or
several, or any action in respect thereof, to which that Underwriter Indemnified Party
may become subject, under the Securities Act or otherwise, insofar as such loss, claim,
damage, expense, liability, action, investigation or proceeding arises out of or is
based upon (i)&nbsp;any untrue statement or alleged untrue statement of a material fact
contained in any Preliminary Prospectus, any Issuer Free Writing Prospectus, any
&#147;issuer information&#148; filed or required to be filed pursuant to Rule 433(d) of the Rules
and Regulations, any Registration Statement or the Prospectus, or in any amendment or
supplement thereto or any document incorporated by reference therein or (ii)&nbsp;the
omission or alleged omission to state in any Preliminary Prospectus, any Issuer Free
Writing Prospectus, any &#147;issuer information&#148; filed or required to be filed pursuant to
Rule 433(d) of the Rules and Regulations, any Registration Statement or the Prospectus,
or in any amendment or supplement thereto or any document incorporated by reference
therein, a material fact required to be stated therein or necessary to make the
statements therein not misleading and shall reimburse each Underwriter Indemnified
Party promptly upon demand for any legal or other expenses reasonably incurred by that
Underwriter Indemnified Party in connection with investigating or preparing to defend
or defending against or appearing as a third party witness in connection with any such
loss, claim, damage, liability or action as such expenses are incurred; <I>provided</I>,
<I>however</I>, that the Company shall not be liable in any such case to the extent that any
such loss, claim, damage, liability or action arises out of or is based upon an untrue
statement or alleged untrue statement in or omission or alleged omission from the
Preliminary Prospectus, the Registration Statement or the Prospectus or any such
amendment or supplement in reliance upon and in conformity with written information
furnished to the Company through the Representative by or on behalf of any Underwriter
specifically for use therein, which information the parties hereto agree is limited to
the Underwriters&#146; Information (as defined in Section&nbsp;17). This indemnity agreement is
not exclusive and will be in addition to any liability which the Company might
otherwise have and shall not limit any rights or remedies which may otherwise be
available at law or in equity to each Underwriter Indemnified Party.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Each Underwriter, severally and not jointly, shall indemnify and hold harmless
the Company, its directors, its officers who signed the Registration Statement and each
person, if any, who controls the Company within the meaning of Section&nbsp;15 of the
Securities Act or Section&nbsp;20 of the Exchange Act (collectively, the &#147;Company
Indemnified Parties&#148; and each, a &#147;Company Indemnified Party&#148;) against any loss, claim,
damage, expense or liability whatsoever (or any action,</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->32<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #textcolor#; background: #bgcolor#">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>investigation or proceeding in respect thereof), joint or several, or any action in
respect thereof, to which the Company Indemnified Parties may become subject, under
the Securities Act or otherwise, insofar as such loss, claim, damage, expense,
action, investigation or proceeding arises out of or is based upon (i)&nbsp;any untrue
statement or alleged untrue statement of a material fact contained in the
Preliminary Prospectus, the Registration Statement or the Prospectus or in any
amendment or supplement thereto or (ii)&nbsp;the omission or alleged omission to state in
any Preliminary Prospectus, the Registration Statement or the Prospectus or in any
amendment or supplement thereto a material fact required to be stated therein or
necessary to make the statements therein not misleading, but in each case only to
the extent that the untrue statement or alleged untrue statement or omission or
alleged omission was made in reliance upon and in conformity with written
information furnished to the Company through the Representative by or on behalf of
the Underwriters specifically for use therein, which information the parties hereto
agree is limited to the Underwriters&#146; Information (as defined in Section&nbsp;17). The
Underwriters shall reimburse the Company Indemnified Parties for any legal or other
expenses reasonably incurred by such parties in connection with investigating or
preparing to defend or defending against or appearing as third party witness in
connection with any such loss, claim, damage, expense, liability, action,
investigation or proceeding, as such expenses are incurred. This indemnity
agreement is not exclusive and will be in addition to any liability which the
Underwriters might otherwise have and shall not limit any rights or remedies which
may otherwise be available at law or in equity to the Company Indemnified Parties.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Promptly after receipt by an indemnified party under this Section&nbsp;7 of notice
of any claim or the commencement of any action, the indemnified party shall, if a claim
in respect thereof is to be made against the indemnifying party under this Section&nbsp;7,
notify the indemnifying party in writing of the claim or the commencement of that
action; <I>provided</I>, <I>however</I>, that the failure to notify the indemnifying party shall not
relieve it from any liability which it may have under this Section&nbsp;7 except to the
extent it has been materially prejudiced by such failure; and <I>provided further </I>that the
failure to notify the indemnifying party shall not relieve it from any liability which
it may have to an indemnified party otherwise than under this Section&nbsp;7. If any such
claim or action shall be brought against an indemnified party, and it shall notify the
indemnifying party thereof, the indemnifying party shall be entitled to participate
therein and, to the extent that it wishes, jointly with any other similarly notified
indemnifying party, to assume the defense thereof with counsel reasonably satisfactory
to the indemnified party (which counsel shall not, except with the written consent of
the indemnified party, be counsel to the indemnifying party). After notice from the
indemnifying party to the indemnified party of its election to assume the defense of
such claim or action, the indemnifying party shall not be liable to the indemnified
party under this Section&nbsp;7 for any legal or other expenses subsequently incurred by the
indemnified party in connection with the defense thereof other than reasonable costs of
investigation; <I>provided</I>, <I>however</I>, that any indemnified party shall have the right to
employ separate counsel in any such
</TD>
</TR>
</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->33<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">action and to participate in the defense thereof but the fees and expenses of such
counsel shall be at the expense of such indemnified party unless (i)&nbsp;the employment
thereof has been specifically authorized by the indemnifying party in writing, (ii)
such indemnified party shall have been advised by such counsel that there may be one
or more legal defenses available to it which are different from or additional to
those available to the indemnifying party and in the reasonable judgment of such
counsel it is advisable for such indemnified party to employ separate counsel or
(iii)&nbsp;the indemnifying party has failed to assume the defense of such action and
employ counsel reasonably satisfactory to the indemnified party within a reasonable
period of time after notice of the commencement of the action or the indemnifying
party does not diligently defend the action after assumption of the defense, in
which case, if such indemnified party notifies the indemnifying party in writing
that it elects to employ separate counsel at the expense of the indemnifying party,
the indemnifying party shall not have the right to assume the defense or continue
the defense, as the case may be, of such action on behalf of such indemnified party,
it being understood, however, that the indemnifying party shall not, in connection
with any one such action or separate but substantially similar or related actions in
the same jurisdiction arising out of the same general allegations or circumstances,
be liable for the reasonable fees and expenses of more than one separate firm of
attorneys at any time for all such indemnified parties, which firm shall be
designated in writing by Cowen, if the indemnified parties under this Section&nbsp;7
consist of any Underwriter Indemnified Party, or by the Company if the indemnified
parties under this Section&nbsp;7 consist of any Company Indemnified Parties. Each
indemnified party, as a condition of the indemnity agreements contained in Sections
7(a) and 7(b), shall use all reasonable efforts to cooperate with the indemnifying
party in the defense of any such action or claim. Subject to this Section&nbsp;7(c), the
amount payable by an indemnifying party under Section&nbsp;7 shall include, but not be
limited to, (x)&nbsp;reasonable legal fees and expenses of counsel to the indemnified
party and any other reasonable expenses incurred in investigating, or preparing to
defend or defending against, or appearing as a third party witness in respect of, or
otherwise incurred in connection with, any action, investigation, proceeding or
claim, and (y)&nbsp;all amounts paid in settlement of any of the foregoing. No
indemnifying party shall, without the prior written consent of the indemnified
parties, settle or compromise or consent to the entry of judgment with respect to
any pending or threatened action or any claim whatsoever, in respect of which
indemnification or contribution could be sought under this Section&nbsp;7 (whether or not
the indemnified parties are actual or potential parties thereto), unless such
settlement, compromise or consent (i)&nbsp;includes an unconditional release of each
indemnified party in form and substance reasonably satisfactory to such indemnified
party from all liability arising out of such action or claim and (ii)&nbsp;does not
include a statement as to or an admission of fault, culpability or a failure to act
by or on behalf of any indemnified party. Subject to the provisions of Section 7(d)
below, no indemnifying party shall be liable for any settlement of any such action
effected without its written consent (which consent shall not be unreasonably
withheld), but if settled with its written consent or if there be a final judgment
for the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->34<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">plaintiff in any such action, the indemnifying party agrees to indemnify and hold
harmless any indemnified party from and against any loss or liability by reason of
such settlement or judgment.
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If at any time an indemnified party shall have requested that an indemnifying
party reimburse the indemnified party for fees and expenses of counsel, such
indemnifying party agrees that it shall be liable for any settlement of the nature
contemplated by this Section&nbsp;7 effected without its written consent if (i)&nbsp;such
settlement is entered into more than 45&nbsp;days after receipt by such indemnifying party
of the request for reimbursement, (ii)&nbsp;such indemnifying party shall have received
notice of the terms of such settlement at least 30&nbsp;days prior to such settlement being
entered into and (iii)&nbsp;such indemnifying party shall not have reimbursed such
indemnified party in accordance with such request prior to the date of such settlement.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(e)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If the indemnification provided for in this Section&nbsp;7 is unavailable or
insufficient to hold harmless an indemnified party under Section 7(a) or 7(b), then
each indemnifying party shall, in lieu of indemnifying such indemnified party,
contribute to the amount paid or payable or otherwise incurred by such indemnified
party as a result of such loss, claim, damage or liability, or action, investigation or
proceeding in respect thereof, as incurred, (i)&nbsp;in such proportion as shall be
appropriate to reflect the relative benefits received by the Company, on the one hand,
and the Underwriters, on the other, from the offering of the Stock or (ii)&nbsp;if the
allocation provided by clause (i)&nbsp;above is not permitted by applicable law, in such
proportion as is appropriate to reflect not only the relative benefits referred to in
clause (i)&nbsp;above but also the relative fault of the Company, on the one hand, and the
Underwriters, on the other, with respect to the statements or omissions, acts or
failures to act which resulted in such loss, claim, damage, expense or liability, or
action, investigation or proceeding in respect thereof, as well as any other relevant
equitable considerations. The relative benefits received by the Company, on the one
hand, and the Underwriters, on the other, with respect to such offering shall be deemed
to be in the same proportion as the total net proceeds from the offering of the Stock
purchased under this Agreement (before deducting expenses) received by the Company bear
to the total underwriting discounts and commissions received by the Underwriters with
respect to the Stock purchased under this Agreement, in each case as set forth in the
table on the cover page of the Prospectus. The relative fault shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement of a
material fact or the omission or alleged omission to state a material fact relates to
information supplied by the Company, on the one hand, or the Underwriters, on the
other, the intent of the parties and their relative knowledge, access to information
and opportunity to correct or prevent such untrue statement, omission, act or failure
to act; <I>provided </I>that the parties hereto agree that the written information furnished
to the Company through the Representative by or on behalf of the Underwriters for use
in any Preliminary Prospectus, either of the Registration Statement or the Prospectus,
or in any amendment or supplement thereto, consists solely of the Underwriters&#146;</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->35<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #textcolor#; background: #bgcolor#">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Information, as defined in Section&nbsp;17. The Company and the Underwriters agree that
it would not be just and equitable if contributions pursuant to this Section 7(e)
were to be determined by pro rata allocation (even if the Underwriters were treated
as one entity for such purpose) or by any other method of allocation which does not
take into account the equitable considerations referred to herein. The amount paid
or payable by an indemnified party as a result of the loss, claim, damage, expense,
liability, action, investigation or proceeding in respect thereof, referred to above
in this Section&nbsp;7(e), shall be deemed to include, for purposes of this Section&nbsp;7(e),
any legal or other expenses reasonably incurred by such indemnified party in
connection with investigating, preparing to defend or defending against or appearing
as a third party witness in respect of, or otherwise incurred in connection with,
any such loss, claim, damage, expense, liability, action, investigation or
proceeding. Notwithstanding the provisions of this Section&nbsp;7(e), no Underwriter
shall be required to contribute any amount in excess of the amount by which the
total price at which the Stock underwritten by it and distributed to the public were
offered to the public less the amount of any damages which such Underwriter has
otherwise paid or become liable to pay by reason of any untrue or alleged untrue
statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall
be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Underwriters&#146; obligations to contribute as provided in this Section 7(e) are several in
proportion to their respective underwriting obligations and not joint.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>8. </I><FONT style="font-variant: SMALL-CAPS"><I>Termination</I></FONT>. The obligations of the Underwriters hereunder may be terminated by Cowen, in
its absolute discretion, by notice given to and received by the Company prior to delivery of and
payment for the Firm Stock if, prior to that time, any of the events described in Sections&nbsp;6(i),
6(k) or 6(l) have occurred or if the Underwriters shall decline to purchase the Stock for any
reason permitted under this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>9. </I><FONT style="font-variant: SMALL-CAPS"><I>Reimbursement of Underwriters&#146; Expenses</I></FONT>. Notwithstanding anything to the contrary in this
Agreement, if (a)&nbsp;this Agreement shall have been terminated pursuant to Section&nbsp;8 or 10, (b)&nbsp;the
Company shall fail to tender the Stock for delivery to the Underwriters for any reason not
permitted under this Agreement, or (c)&nbsp;the Underwriters shall decline to purchase the Stock for any
reason permitted under this Agreement, the Company shall reimburse the Underwriters for the fees
and expenses of their counsel and for such other out-of-pocket expenses as shall have been
reasonably incurred by them in connection with this Agreement and the proposed purchase of the
Stock, and upon demand the Company shall pay the full amount thereof to Cowen. If this Agreement
is terminated pursuant to Section&nbsp;10 by reason of the default of one or more Underwriters, the
Company shall not be obligated to reimburse any defaulting Underwriter on account of those expenses
to the extent incurred by such defaulting Underwriter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>10. </I><FONT style="font-variant: SMALL-CAPS"><I>Substitution of Underwriters</I></FONT>. If any Underwriter or Underwriters shall default in its or
their obligations to purchase shares of Stock hereunder on any Closing Date and the aggregate
number of shares which such defaulting Underwriter or Underwriters agreed but failed to purchase
does not exceed ten percent (10%) of the total number of shares to be purchased by all
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->36<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Underwriters
on such Closing Date, the other Underwriters shall be obligated severally, in proportion to their
respective commitments hereunder, to purchase the shares which such defaulting Underwriter or
Underwriters agreed but failed to purchase on such Closing Date. If any Underwriter or
Underwriters shall so default and the aggregate number of shares with respect to which such default
or defaults occur is more than ten percent (10%) of the total number of shares to be purchased by
all Underwriters on such Closing Date and arrangements satisfactory to the Representative and the
Company for the purchase of such shares by other persons are not made within forty-eight (48)&nbsp;hours
after such default, this Agreement shall terminate.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the remaining Underwriters or substituted Underwriters are required hereby or agree to take
up all or part of the shares of Stock of a defaulting Underwriter or Underwriters on such Closing
Date as provided in this Section&nbsp;10, (i)&nbsp;the Company shall have the right to postpone the Closing
Dates for a period of not more than five (5)&nbsp;full business days in order that the Company may
effect whatever changes may thereby be made necessary in the Registration Statement or the
Prospectus, or in any other documents or arrangements, and the Company agrees promptly to file any
amendments to the Registration Statement or supplements to the Prospectus which may thereby be made
necessary, and (ii)&nbsp;the respective numbers of shares to be purchased by the remaining Underwriters
or substituted Underwriters shall be taken as the basis of their underwriting obligation for all
purposes of this Agreement. Nothing herein contained shall relieve any defaulting Underwriter of
its liability to the Company or the other Underwriters for damages occasioned by its default
hereunder. Any termination of this Agreement pursuant to this Section&nbsp;10 shall be without
liability on the part of any non-defaulting Underwriter or the Company, except that expenses to be
paid or reimbursed pursuant to Sections&nbsp;5 and 9 and the provisions of Section&nbsp;7 shall not terminate
and shall remain in effect.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>11. </I><FONT style="font-variant: SMALL-CAPS"><I>Absence of Fiduciary Relationship</I></FONT>. The Company acknowledges and agrees that:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>each Underwriter&#146;s responsibility to the Company is solely contractual in
nature, the Representative has been retained solely to act as underwriters in
connection with the sale of the Stock and no fiduciary, advisory or agency relationship
between the Company and the Representative has been created in respect of any of the
transactions contemplated by this Agreement, irrespective of whether the Representative
has advised or is advising the Company on other matters;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the price of the Stock set forth in this Agreement was established by the
Company following discussions and arms-length negotiations with the Representative, and
the Company is capable of evaluating and understanding, and understands and accepts,
the terms, risks and conditions of the transactions contemplated by this Agreement;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>it has been advised that the Representative and its affiliates are engaged in a
broad range of transactions which may involve interests that differ from those of the
Company and that the Representative has no obligation to disclose such interests and
transactions to the Company by virtue of any fiduciary, advisory or agency
relationship; and</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->37<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>it waives, to the fullest extent permitted by law, any claims it may have
against the Representative for breach of fiduciary duty or alleged breach of fiduciary
duty and agrees that the Representative shall have no liability (whether direct or
indirect) to the Company in respect of such a fiduciary duty claim or to any person
asserting a fiduciary duty claim on behalf of or in right of the Company, including
stockholders, employees or creditors of the Company.</TD>
</TR>

</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>12. </I><FONT style="font-variant: SMALL-CAPS"><I>Successors; Persons Entitled to Benefit of Agreement</I></FONT>. This Agreement shall inure to the
benefit of and be binding upon the several Underwriters, the Company and their respective
successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to
give any person other than the persons mentioned in the preceding sentence any legal or equitable
right, remedy or claim under or in respect of this Agreement, or any provisions herein contained,
this Agreement and all conditions and provisions hereof being intended to be and being for the sole
and exclusive benefit of such persons and for the benefit of no other person; except that the
representations, warranties, covenants, agreements and indemnities of the Company contained in this
Agreement shall also be for the benefit of the Underwriter Indemnified Parties, and the indemnities
of the several Underwriters shall also be for the benefit of the Company Indemnified Parties. It
is understood that each Underwriter&#146;s responsibility to the Company is solely contractual in nature
and the Underwriters do not owe the Company, or any other party, any fiduciary duty as a result of
this Agreement. No purchaser of any of the Stock from any Underwriter shall be deemed to be a
successor or assign by reason merely of such purchase.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>13. </I><FONT style="font-variant: SMALL-CAPS"><I>Survival of Indemnities, Representations, Warranties, etc.</I></FONT> The respective indemnities,
covenants, agreements, representations, warranties and other statements of the Company and the
several Underwriters, as set forth in this Agreement or made by them respectively pursuant to this
Agreement, shall remain in full force and effect, regardless of any investigation made by or on
behalf of any Underwriter, the Company or any person controlling any of them and shall survive
delivery of and payment for the Stock. Notwithstanding any termination of this Agreement,
including, without limitation, any termination pursuant to Section&nbsp;9 or Section&nbsp;11, the
indemnities, covenants, agreements, representations, warranties and other statements set forth in
Sections&nbsp;2, 5, 8 and 10 and Sections&nbsp;12 through 20, inclusive, of this Agreement shall not
terminate and shall remain in full force and effect at all times.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>14. </I><FONT style="font-variant: SMALL-CAPS"><I>Notices</I></FONT>. All statements, requests, notices and agreements hereunder shall be in writing,
and:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>if to the Underwriters, shall be delivered or sent by mail, telex or facsimile
transmission to Cowen and Company, LLC, 1221 Avenue of the Americas, New York, New York
10020, Attention: Head of Equity Capital Markets (Fax: 646-562-1249), with a copy to
the same address, Attention: Legal Department &#151; General Counsel (Fax: 646-562-1861);
and</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>if to the Company, shall be delivered or sent by mail, telex or facsimile
transmission to Moog Inc., 6860 Seneca Street, P.O. Box 18, East Aurora, New York
14203, Attention: John R. Scannell (Fax: 716-687-4388), with a copy to </TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->38<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #textcolor#; background: #bgcolor#">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Hodgson Russ
LLP, Suite&nbsp;2000, One M&#038;T Plaza, Buffalo, New York 14203, Attention: John B. Drenning,
Esq. and John Zak, Esq. (Fax: 716-849-0349).</TD>
</TR>

</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>15. </I><FONT style="font-variant: SMALL-CAPS"><I>Definition of Certain Terms</I></FONT>. For purposes of this Agreement, (a) &#147;business day&#148; means any
day on which the New York Stock Exchange, Inc. is open for trading and (b) &#147;subsidiary&#148; has the
meaning set forth in Rule&nbsp;405 of the Rules and Regulations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>16. </I><FONT style="font-variant: SMALL-CAPS"><I>Governing Law</I></FONT>. This Agreement shall be governed by and construed in accordance with the
laws of the State of New York, including, without limitation, Section&nbsp;5-1401 of the New York
General Obligations Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>17. </I><FONT style="font-variant: SMALL-CAPS"><I>Underwriters&#146; Information</I></FONT>. The parties hereto acknowledge and agree that, for all
purposes of this Agreement, the Underwriters&#146; Information consists solely of the following
information in the Prospectus: (i)&nbsp;the table on the front cover page concerning the terms of the
offering by the Underwriters; and (ii)&nbsp;the statements concerning the Underwriters contained in the
tenth paragraph under the heading &#147;Underwriting&#148;.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>18. </I><FONT style="font-variant: SMALL-CAPS"><I>Authority of the Representative</I></FONT>. In connection with this Agreement, you will act for and
on behalf of the several Underwriters, and any action taken under this Agreement by the
Representative will be binding on all Underwriters.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>19. </I><FONT style="font-variant: SMALL-CAPS"><I>Partial Unenforceability</I></FONT>. The invalidity or unenforceability of any Section, paragraph or
provision of this Agreement shall not affect the validity or enforceability of any other Section,
paragraph or provision hereof. If any Section, paragraph, clause or provision of this Agreement is
for any reason determined to be invalid or unenforceable, there shall be deemed to be made such
minor changes (and only such minor changes) as are necessary to make it valid and enforceable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>20. </I><FONT style="font-variant: SMALL-CAPS"><I>General</I></FONT>. This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes
all prior written or oral and all contemporaneous oral agreements, understandings and negotiations
with respect to the subject matter hereof. In this Agreement, the masculine, feminine and neuter
genders and the singular and the plural include one another. The section headings in this
Agreement are for the convenience of the parties only and will not affect the construction or
interpretation of this Agreement. This Agreement may be amended or modified, and the observance of
any term of this Agreement may be waived, only by a writing signed by the Company and the
Representative.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>21. </I><FONT style="font-variant: SMALL-CAPS"><I>Counterparts</I></FONT>. This Agreement may be signed in any number of counterparts, each of which
shall be an original, with the same effect as if the signatures thereto and hereto were upon the
same instrument.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->39<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the foregoing is in accordance with your understanding of the agreement between the Company
and the several Underwriters, kindly indicate your acceptance in the space provided for that
purpose below.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Very truly yours,<BR>
<BR>
MOOG INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ John Scannell
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">John Scannell&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">CFO&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>

    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
</TR>
<TR>
    <TD colspan="3" align="left">Accepted as of<BR>
the date first above written:<BR>
<BR>
COWEN AND COMPANY, LLC<BR>
<BR>
Acting on its own behalf<br>
and as Representative of the several <br>
Underwriters named on Schedule&nbsp;A hereto.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top" align="left">&nbsp;</TD>

</TR><TR>

    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Jonathan C. Biele
&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
</TR><TR>

    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Authorized Signatory&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
</TR><TR>

    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->40<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>SCHEDULE A</U>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Number of Firm Shares</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Name</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000">to be Purchased</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cowen and Company, LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,246,500</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">HSBC Securities (USA)&nbsp;Inc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">73,769</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">RBS Securities Inc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44,109</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">PNC Capital Markets LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38,278</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Mitsubishi UFJ Securities (USA), Inc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32,448</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SG Americas Securities, LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29,406</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">RBC Capital Markets Corporation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17,745</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Comerica Securities, Inc.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17,745</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,500,000</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->41<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>SCHEDULE B</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>GENERAL USE FREE WRITING PROSPECTUSES</B></U>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">None.

</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->42<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>SCHEDULE C</U>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Moog Inc. Retirement Plan Trust</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Richard A. Aubrecht</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Timothy P. Balkin</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Robert R. Banta</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">5.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Martin J. Berardi</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">6.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Robert T. Brady</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">7.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>John B. Drenning</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">8.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Sasidhar Eranki</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">9.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Donald R. Fishback</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">10.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Joe C. Green</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">11.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Peter J. Gunderman</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">12.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>John D. Hendrick</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">13.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Jay K. Hennig</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">14.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Stephen A. Huckvale</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">15.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Warren C. Johnson</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">16.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Kraig H. Kayser</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">17.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Brian J. Lipke</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">18.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Robert H. Maskrey</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">19.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Albert F. Myers</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">20.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Raymond W. Boushie</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">21.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Lawrence J. Ball</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">22.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>John R. Scannell</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">23.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Harald E. Seiffer</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left">24.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Jennifer Walter</TD>
</TR>

</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->43<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>SCHEDULE D</U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Total: $73,750,000
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Shares offered by the Company: 2,500,000 shares
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Price to public: $29.50 per share
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Net proceeds to the Company: $70,062,500
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Overallotment option: 375,000 shares
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Closing date: October&nbsp;2, 2009
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->44<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>EXHIBIT I</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>FORM OF LOCK-UP AGREEMENT</B></U>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2009
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Cowen and Company, LLC<BR>
1221 Avenue of the Americas<BR>
New York, New York 10020<BR>
Re: Moog Inc. Shares of Common Stock

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Dear Sirs:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In order to induce Cowen and Company, LLC (&#147;Cowen&#148;) to enter into a certain underwriting
agreement (the &#147;Underwriting Agreement&#148;) with Moog Inc., a New York corporation (the &#147;Company&#148;),
with respect to the public offering of shares of the Company&#146;s Class&nbsp;A Common Stock, par value
$1.00 per share (the &#147;Class&nbsp;A Common Stock,&#148; and together with the Company&#146;s Class&nbsp;B Common Stock,
par value $1.00 per share, the &#147;Common Stock&#148;), the undersigned hereby agrees that for a period of
90&nbsp;days following the date of the Underwriting Agreement, the undersigned will not, without the
prior written consent of Cowen, directly or indirectly, (i)&nbsp;offer, sell, assign, transfer, pledge,
contract to sell, or otherwise dispose of, any shares of Common Stock (including, without
limitation, Common Stock which may be deemed to be beneficially owned by the undersigned in
accordance with the rules and regulations promulgated under the Securities Act of 1933, as the same
may be amended or supplemented from time to time (such shares, the &#147;Beneficially Owned Shares&#148;)) or
securities convertible into or exercisable or exchangeable in Common Stock, (ii)&nbsp;enter into any
swap, hedge or similar agreement or arrangement that transfers, in whole or in part, the economic
risk of ownership of the Beneficially Owned Shares or securities convertible into or exercisable or
exchangeable in Common Stock or (iii)&nbsp;engage in any short selling of the Common Stock.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If (i)&nbsp;the Company issues an earnings release or material news or a material event relating to
the Company occurs during the last 17&nbsp;days of the lock-up period, or (ii)&nbsp;prior to the expiration
of the lock-up period, the Company announces that it will release earnings results during the
16-day period beginning on the last day of the lock-up period, the restrictions imposed by this
Agreement shall continue to apply until the expiration of the 18-day period beginning on the
issuance of the earnings release or the occurrence of the material news or material event.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Anything contained herein to the contrary notwithstanding, any person to whom shares of Common
Stock or Beneficially Owned Shares are transferred from the undersigned shall be bound by the terms
of this Agreement.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->45<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, the undersigned hereby waives, from the date hereof until the expiration of the
90-day period following the date of the Underwriting Agreement, any and all rights, if any, to
request or demand registration pursuant to the Securities Act of any shares of Common Stock that
are registered in the name of the undersigned or that are Beneficially Owned Shares.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;REMAINDER OF PAGE INTENTIONALLY LEFT BLANK.
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">SIGNATURE PAGE FOLLOWS.&#093;

</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->46<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&#091;Signatory&#093;<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->47<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>l37710exv5w1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv5w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>EXHIBIT 5.1</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">October&nbsp;2, 2009
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Moog Inc.<BR>
East Aurora, New York 14052
</DIV>


<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="6%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Re:</TD>
    <TD>&nbsp;</TD>
    <TD>Registration Statement on Form&nbsp;S-3<BR>
<U>Registration No.&nbsp;333-162178</U></TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Ladies and Gentlemen:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have acted as counsel to Moog Inc., a New York corporation, (the &#147;Company&#148;) in connection
with the filing with the Securities and Exchange Commission (the &#147;Commission&#148;) on September&nbsp;28,
2009 of a registration statement on Form S-3 (as amended, the &#147;Registration Statement&#148;), including
the prospectus constituting a part thereof dated September&nbsp;28, 2009 and a prospectus supplement
dated September&nbsp;29, 2009 (collectively the &#147;Prospectus&#148;), which relates to the registration for
sale by the Company of 2,500,000 shares of Class&nbsp;A Common Stock, par value $1.00 per share of the
Company (plus an additional 375,000 of such shares to cover the over-allotments) (collectively the
&#147;Shares&#148;)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This letter is being furnished at your request and in accordance with the requirements of Item
601(b)(5) of Regulation&nbsp;S-K under Securities Act of 1933, as amended, (the &#147;Act&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The opinions set forth in this letter are subject to the following qualifications:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;In giving the opinions set forth in this letter, we have examined originals or copies,
certified or otherwise identified to our satisfaction, of (a)&nbsp;the Registration Statement, (b)&nbsp;the
Underwriting Agreement in the form included as Exhibit&nbsp;1.1 to the Company&#146;s Current Report on Form
8-K filed with the Commission on the date of this letter (the &#147;Underwriting Agreement&#148;) (c)&nbsp;the
Certificate of Incorporation and the By-Laws of the Company (d)&nbsp;such evidence of incumbency of
directors and officers of the Company as we have deemed appropriate, (e)&nbsp;such evidence of the
corporate proceedings of the Company as we have deemed appropriate, (f)&nbsp;such certificates of
officers of the Company as we have deemed appropriate, (g)&nbsp;such certificates of public officials as
we have deemed appropriate and (h)&nbsp;such agreements and instruments as we have deemed appropriate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;We have assumed without any inquiry or other investigation (a)&nbsp;the legal capacity of each
natural person, (b)&nbsp;the genuineness of signatures, the authenticity of any document submitted to us
as an original, the conformity to the original of any document submitted to us as a copy and the
authenticity of the original of any document submitted to us as a copy and (c)&nbsp;the accuracy on the
date of this letter as well as on the date made of each statement as to any factual matter made in
any document submitted to us.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;We do not express any opinion concerning any law other than the Business Corporation Law of
the State of New York.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;Any opinion set forth in this letter (a)&nbsp;deals only with the specific legal issue or issues
it explicitly addresses and (b)&nbsp;does not address any other matter (including, but not limited to
any matter concerning the contents of the Registration Statement).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;This letter is given without regard to any change after the date of this letter with
respect to any factual or legal matter, and we disclaim any obligation to notify you of any such
change or any effect of any such change on any opinion set forth in this letter.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the qualifications set forth in this letter, it is our opinion that the Shares have
been duly authorized by the Company, and, assuming that the Shares are issued and paid for as
contemplated by the Underwriting Agreement, the Shares will be legally issued, fully paid and
nonassessable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We consent to the use of this letter as an exhibit to the Registration Statement and to the
references to us under the heading &#147;Legal Matters&#148; in the Prospectus that is a part of the
Registration Statement. In giving such consent, we do not admit that we are in the category of
persons whose consent is required under Section&nbsp;7 of the Act or the rules and regulations of the
Commission thereunder.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Very truly yours,<BR>
<BR>
HODGSON RUSS LLP<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ John J. Zak
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">John J. Zak&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>l37710exv99w1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>EXHIBIT 99.1</B>
</DIV>


<DIV align="right" style="font-size: 16pt; margin-top: 6pt"><B>Press information</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><FONT style="font-size:14pt"><B>MOOG</B></FONT> INC., EAST AURORA, NEW YORK 14052 &nbsp;&nbsp;TEL-716/652-2000 &nbsp;&nbsp;FAX -716/687-4457
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD nowrap valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>release date</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Immediate
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>contact</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ann Marie Luhr</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">September&nbsp;30, 2009
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">716-687-4225</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>MOOG INC. ANNOUNCES PRICING FOR<BR>
CLASS A COMMON STOCK OFFERING</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">East Aurora, NY, September&nbsp;30, 2009 &#151; Moog Inc. (NYSE:MOG.A and MOG.B) announced today that it has
priced its public offering of 2.5&nbsp;million shares of Class&nbsp;A common stock at $29.50 per share. Moog
has granted the underwriters a 30-day option to purchase up to an additional 375,000 shares of
Class&nbsp;A common stock to cover over-allotments, if any. Moog expects to use the net proceeds from
this offering to repay a portion of the indebtedness recently incurred under its revolving bank
credit facility to acquire GE Aviation Systems&#146; flight control actuation business located in
Wolverhampton, U.K. All of the shares were offered by Moog pursuant to a prospectus supplement
under Moog&#146;s existing shelf registration statement. Cowen and Company, LLC acted as the lead
manager for the offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This press release does not constitute an offer to sell or the solicitation of an offer to buy nor
will there be any sale of these securities in any state in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the securities laws of any such
state. A preliminary prospectus supplement and accompanying prospectus related to the offering have
been filed with the U.S. Securities and Exchange Commission and are available on its website,
www.sec.gov. Copies of the final prospectus, when available, can be obtained by eligible investors
from their Cowen and Company, LLC sales representative, or from the offices of Cowen and Company,
LLC c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Attn:
Prospectus Department. Phone (631)&nbsp;274-2806 / Fax (631)&nbsp;254-7140.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Moog Inc. is a worldwide designer, manufacturer, and integrator of precision control components and
systems. Moog&#146;s high-performance systems control military and commercial aircraft, satellites and
space vehicles, launch vehicles, missiles, automated industrial machinery, wind energy, marine and
medical equipment.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>5
<FILENAME>l37710exv99w2.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w2</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>EXHIBIT 99.2</B>
</DIV>


<DIV align="right" style="font-size: 16pt; margin-top: 6pt"><B>Press information</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><FONT style="font-size:14pt"><B>MOOG</B></FONT>
INC., EAST AURORA, NEW YORK 14052 &nbsp; TEL-716/652-2000&nbsp;&nbsp;&nbsp;FAX -716/687-4457
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
     <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD nowrap valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>release date</B>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Immediate
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>contact</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ann Marie Luhr</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;2, 2009
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">716-687-4225</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>MOOG INC. ANNOUNCES CLOSING OF SALE OF<BR>
2,675,000 SHARES OF CLASS A COMMON STOCK</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">East Aurora, NY, October&nbsp;2, 2009 &#151; Moog Inc. (NYSE:MOG.A and MOG.B) today announced that it has
closed its public offering and sale of 2,675,000 shares of Class&nbsp;A common stock (which number of
shares includes 175,000 shares sold to the underwriters&#146; pursuant to the exercise in part of their
over-allotment option) at a price of $29.50 per share. Net proceeds to Moog from the offering were
approximately $75&nbsp;million. Moog will use the net proceeds from this offering to repay a portion of
the indebtedness recently incurred under its revolving bank credit facility to acquire GE Aviation
Systems&#146; flight control actuation business. All of the shares were offered by Moog pursuant to a
prospectus supplement under Moog&#146;s existing shelf-registration statement. Cowen and Company, LLC
acted as the lead manager for the offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This press release does not constitute an offer to sell or the solicitation of an offer to buy nor
will there be any sale of these securities in any state in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the securities laws of any such
state. A final prospectus supplement and accompanying prospectus related to the offering have been
filed with the U.S. Securities and Exchange Commission and are available on its website,
<U>www.sec.gov</U>. A copy of the final prospectus can be obtained by eligible investors from
their Cowen and Company, LLC sales representative or from the offices of Cowen and Company, LLC c/o
Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Attn: Prospectus
Department. Phone (631)&nbsp;274-2806 / Fax (631)&nbsp;254-7140.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Moog Inc. is a worldwide designer, manufacturer, and integrator of precision control components and
systems. Moog&#146;s high-performance systems control military and commercial aircraft, satellites and
space vehicles, launch vehicles, missiles, automated industrial machinery, wind energy, marine and
medical equipment.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
